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Genetic Discrimination in the Workplace: An
Overview of Existing Protections
Melinda B. Kaufinann*
Our fate is in our genes.
I. INTRODUCTION
The sophistication of genetic technology has grown at an amazing
rate. As this technology improves, scientists can predict more genetic
markers and traits than ever before.2 Genetic information can poten-
tially benefit society because it is likely to lead to cures and treatments
for currently incurable genetic disorders. This knowledge, however,
also has the potential to create a biological underclass of people based
on their latent genetic disorders. Some critics have gone so far as to
suggest that knowledge of genetic fitness could be used to choose
between parents in custody battles, or to determine whether potential
adoptive parents are suitable.3 More commonly, however, genetic
technology can be used to screen applicants for both employment and
health insurance.
Several studies have noted a significant trend in the use of genetic
testing in employment. For example, a 1989 study conducted by the
United States Congress Office of Technology Assessment ("OTA")
that surveyed Fortune 500 companies,4 discovered that of the 330
*Melinda B. Kaufmann is an attorney with the law firm of Stock and Leader, P.C., in
York, Pennsylvania. She practices primarily employment law and school law.
1. Leon Jaroff, The Gene Hunt, TIME, Mar. 20, 1989, at 62, 67 (quoting James
Watson, Director of the Human Genome Project).
2. For example, genetic tests currently available include identification of adult
polycystic kidney disease, fragile X syndrome, sickle cell anemia, Duchenne muscular
dystrophy, cystic fibrosis, Huntington's disease, hemophilia, phenylketonuria, and
retinoblastoma. See OFFICE OF TECH. ASSESSMENT, U.S. CONGRESS, GENETIC MONITORING
AND SCREENING IN THE WORKPLACE 15, tbls. 1-2 (1990) [hereinafter GENETIC MONITORING
SURVEY].
3. See Brian R. Gin, Genetic Discrimination: Huntington's Disease and the
Americans with Disabilities Act, 97 COLUM. L. REV. 1406, 1411 (1997) (suggesting
that in the future adoption agencies may choose suitable parents based on their genetic
potential and that the same information may be used by courts in determining who
should receive custody of children in divorce settlements).
4. See GENETIC MONITORING SURVEY, supra note 2, at 21 tbls.l-5 (asking each
company if it was conducting either "biochemical genetic screening" or "direct DNA
screening" on its employees or potential employees).
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companies responding, twelve companies admitted to currently
conducting genetic tests on employees.5 In a follow-up survey, the
OTA reported that almost half of the health officers and personnel
officers surveyed said their companies would approve of pre-
employment exams to screen applicants for genetic susceptibility to
workplace toxins.6 These numbers are projected to increase as another
survey revealed that fifteen percent of responding companies plan to
use genetic testing as a condition to employment by the year 2000. 7 In
addition, some companies indicated that their future use of genetic
testing could depend upon its cost-effectiveness. 8 At the time of the
survey, however, few of these surveyed companies felt that genetic
testing was cost-effective.9
Currently, some employers already use the results of medical tests
as a hiring criterion before extending a final job offer.1l While the
practice of genetically testing employment applicants is not
widespread, its expansion seems inevitable as the tests become cheaper
and easier for employers to use. Support for this proposition comes
5. See Larry Gostin, Genetic Discrimination: The Use of Genetically Based
Diagnostic and Prognostic Tests by Employers and Insurers, 17 AM. J.L. & MED. 109,
115 (1991). Further, eight companies admitted to utilizing genetic testing in the past.
See id.
6. See OFFICE OF TECH. ASSESSMENT, U.S. CONGRESS, MEDICAL MONITORING AND
SCREENING IN THE WORKPLACE: RESULTS OF A SURVEY-BACKGROUND PAPER 4 (1991)
[hereinafter MEDICAL MONITORING SURVEY]. Congress initially became interested in the
issue of genetic monitoring and screening in the workplace in the late 1970s and early
1980s. See id. at 16. This interest led to hearings by the House Committee on Science
and Technology and an OTA assessment formally labeled The Role of Genetic Testing in
the Prevention of Occupational Diseases in 1983. See id.
7. See Gostin, supra note 5, at 115 (discussing the Northwestern National Life
Insurance Company survey conducted in 1989). Further studies have uncovered
anecdotal information about genetic discrimination in employment. See Paul R.
Billings et al., Discrimination as a Consequence of Genetic Testing, 50 AM. J. HUM.
GENETICS 476 (1992). Billings reported 42 incidents of genetic discrimination, 39 of
which involved insurance or employment. See id. at 478. For example, one insurance
company denied an individual coverage due to his hereditary hemochromatosis, a
condition resulting in excessive iron storage. See id. The insurance company refused
coverage despite the fact that the individual never had even the slightest symptom and
underwent preventative treatment. See id. Another case involved an individual whose
brother was diagnosed with Gaucher Disease. See id. When the individual applied for a
governmental job, the government agency denied him employment because he was a
"carrier, like sickle cell." See id.
8. See MEDICAL MONITORING SURVEY, supra note 6, at 5.
9. See id. at 38.
10. See id. at 44. Specifically, 36% of the companies surveyed admitted to
periodically engaging in health insurance risk assessments of prospective employees.
See id.
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from the Ethical, Legal and Social Implications research component of
the Human Genome Project,"' which has identified the possibility of
employers using the new genetic information for discrimination as one
of the major concerns of increased genetic knowledge. 2 Yet, thus far
no court has directly addressed the issue of genetic testing. 3
This Article discusses the legal and ethical ramifications of using
genetic screening to select job applicants and genetic monitoring of
employees. This Article begins by explaining how genetic testing is
used as a screening and monitoring tool. 4 In doing so, it also traces
the history of discrimination based on genetic testing in the United
States.15 This Article then addresses an individual's potential
protections under the Americans with Disabilities Act ("ADA")
including individuals protected by the ADA, the impact of testing on
job applicants, the requirements of an ADA action, and the Equal
Employment Opportunity Commission's ("EEOC") interpretation of
11. The Human Genome Project is a collection of related, independent research
projects with the ultimate goal of analyzing the structure of human DNA, and mapping
and sequencing the estimated 100,000 human genes. The project began in 1990 and its
estimated completion date is 2005. See Mark A. Rothstein, Genetic Discrimination in
Employment and the Americans with Disabilities Act, 29 Hous. L. REV. 23, 24-25
(1992) (discussing the impact of the Human Genome Project on the operation of the
ADA and the inadequacies of the ADA to protect against genetic based discrimination).
12. See Lynda M. Fox & Sherman G. Finesilver, Genetics and the Workplace: ADA
Applicability to Genetic Information, 26 COLO. LAW. 75, 75 (1997) (citing Using Gene
Tests to Deny Jobs is Ruled Illegal, N.Y. TIMES, Apr. 8, 1995, at A12) (reporting that
the Equal Employment Opportunity Commission considers the use of genetic tests
discriminatory if used to deny employment)).
13. Recently, both current and former employees of a state and federally funded
laboratory filed a claim in the Northern District of California. The claim alleged that the
laboratory performed genetic and other medical tests (specifically for syphilis, sickle
cell, and pregnancy) without informing the applicants of the tests. Further, the claims
alleged violations of the Americans with Disabilities Act ("ADA"), Title VII, and the
right to privacy under both the United States and California Constitutions. See Norman-
Bloodsaw v. Lawrence Berkeley Lab., No. 95-03220 (N.D. Cal. Sept. 3, 1995). The
District Court dismissed all the employees' charges based on motions for dismissal,
improper pleadings, and summary judgment. On appeal, the Ninth Circuit reversed all
but the district court's dismissal of the ADA claims. See Norman-Bloodsaw v. Lawrence
Berkeley Lab., 135 F.3d 1260, 1275 (9th Cir. 1998). The Court of Appeals found that
the plaintiffs stated a claim based on violations of Title VII (the plaintiffs' complaint
alleged that the tests for sickle cell were only given to African Americans, and the
pregnancy tests were only given to women), as well as privacy claims based on
violations of both the United States Constitution and the California Constitution. See
id. at 1269-73. Thus, while the merits of the claims are pending, at least one circuit has
recognized that genetic testing implicates Title VII and privacy claims.
14. See infra Part II.
15. See infra Part ll.B.
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the ADA.' 6 Further, this Article discusses potential claims based on
Title VII of the Civil Rights Act.'7 Next, this Article addresses the
effect of the Occupational Health and Safety Act ("OSHA") on genetic
testing.' 8  It follows with a discussion of the constitutional
ramifications based on privacy rights that arise from genetic testing.' 9
It then chronicles several state efforts to control genetic testing within
their borders. 20  Finally, this Article concludes that current juris-
prudence provides adequate protection against genetic discrimination
based on genetic testing in the employment arena.21 It suggests,
however, that Congress needs to specifically include genetic testing
within the protections of the ADA, in order to stem the present
confusion that has spurred so many states to pass their own genetic
protection laws.
II. GENETIC TESTING-AN OVERVIEW
Every person is genetically unique. An individual's genetic
structure is the blueprint to his or her personal characteristics. A basic
understanding of genetics begins with a discussion of
deoxyribonucleic acid ("DNA"), which is the building block of an
individual's genes. 22  These genes link together to make up
chromosomes. Each individual has 23 pairs of chromosomes that
ultimately determine the individual's genetic traits. Scientists estimate
"that there are over 3 billion base pairs of DNA in the human
genome. ' ' 23 The Human Genome Project began in 1990.24 It is a
collection of related, independent research projects with the ultimate
goal of analyzing the structure of human DNA by mapping and
sequencing the estimated 100,000 human genes. 25 Although its
16. See infra Part III.
17. See infra Part IV.
18. See infra Part V.
19. See infra Part VI.
20. See infra Part VII.
21. See infra Part VIII.
22. See ALTON BIGGS ET AL., BIOLOGY: THE DYNAMICS OF LIFE 312 (1995) (noting that
organisms differ due to variations in the nucleotides of DNA).
23. Id. at 386. The human genome is the approximately 100,000 genes in the 46
human chromosomes. See id.
24. See Rothstein, supra note 11, at 24 (noting that the Human Genome Project is
widely considered to be one of the most significant scientific projects ever conducted).
25. See id. at 24 (citing OFFICE OF TECH. ASSESSMENT, U.S. CONGRESS, MAPPING OUR
GENES-THE GENOME PROJECTS: How BIG, How FAST? 4 (1988)).
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estimated completion date is 2005,26 only a few thousand of the
known genes have been mapped on particular chromosomes to date.27
Some genetic traits can be linked to a single, identifiable gene.
Geneticists have been able to identify over 200 human traits that are
coded by a single, dominant allele or contrasting gene.28 About 250
other traits have been traced to homozygous recessive genes.29 Other
genetic traits, however, are controlled by multiple genes.3" As
scientists learn more about genetics, it will become possible to
determine an individual's genetic susceptibility to different conditions
based on an examination of the individual's genetic make-up. Genetic
testing allows doctors to predict a person's potential for future health
problems and behavior disorders.3 Testing to identify genetic
disorders can occur through two processes: genetic screening and
genetic monitoring.
A. The Types of Testing-Tools For the Employer
Genetic screening is a one-time test performed on job applicants in
order to determine their current genetic predisposition.32 Employers
may genetically screen applicants using two methods-each can be used
to identify the presence of genetic traits that render a person hyper-
susceptible to certain toxins33 or detect general genetic conditions that
are not necessarily associated with occupational diseases.34 The first
26. See id.
27. See BIGGS, supra note 22, at 386.
28. See ALBERT TOWLE, MODERN BIOLOGY 171 (1993). Huntington's disease is an
example of a trait linked to a single allele or dominant contrasting gene. See id. This
disease causes "loss of muscle control, uncontrollable physical spasms, severe mental
illness, and eventual death." Id. at 172.
29. See id. at 171. A homozygous recessive gene is a gene that is directly linked to a
single genetic trait. For example, cystic fibrosis and phenylketonuria (PKU) are two
genetic diseases linked to a single, recessive gene. See BIGGS, supra note 22, at 358-59.
30. See Towle supra note 28, at 173. Thus, in order for an individual to manifest such
a trait, he or she would have to possess a certain combination of genes.
3 1. See Kristie A. Deyerle, Comment, Genetic Testing in the Workplace: Employer
Dream, Employee Nightmare-Legislative Regulation in the United States and the
Federal Republic of Germany, 18 CoMP. LAB. L.J. 547, 549 (1997) (noting the
implications of genetic information for family members and its potential to stigmatize
individuals).
32. See GENETIC MONITORING SURVEY, supra note 2, at 5 (noting that the focus of
genetic screening is the "preexisting genetic makeup" that workers bring to the job).
33. See id. For example, an employer may screen applicants for susceptibility to
benzene before beginning work when large amounts of benzene will be present in the
workplace.
34. See id. For example, an employee could be tested for sickle cell trait, or
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method, and the one most often used in the employment setting, is
biochemical genetic screening.35 This method consists of the analysis
of mutant genes based on altered proteins or enzymes in the
individual's bloodstream.3 6 Biochemical genetic screening may be
accomplished through either a simple blood test or the collection of a
tissue sample. The second method is direct-DNA screening.37 This
method involves the direct examination of the individual's DNA.
Several reasons may motivate employers to conduct these or similar
medical tests. For example, some employers simply may be
complying with OSHA guidelines that require medical testing. 38
Alternatively, employers may be paternalistically shielding susceptible
workers from known toxins. The employer's rationale, however, may
also be self-serving. For instance, as employers increasingly provide
health benefits to workers, genetic and medical screening may be used
to weed out job applicants or workers who are likely to have higher
insurance costs. 3 9 In addition, employers may be interested in
decreasing the costs associated with occupational illnesses by
eliminating workers with a genetic predisposition to those diseases .'
The second type of genetic testing is genetic monitoring. These
tests involve periodic testing of individuals to evaluate any
modifications that may have occurred in their genetic material.4 These
tests help determine the effect of workplace toxins on an employee's
Huntington's disease, neither of which is triggered by workplace toxins.
35. See id., at 21 tbls.1-5 (tracking Fortune 500 companies' use of genetic
screening).
36. See id. at 10 (noting that the strides in DNA technology have increased our
capability to examine the genetic basis for disease and to protect and to diagnose such
diseases in large population groups).
37. See id. at 21 tbls.1-5. At the time of the survey, no employers reported current
use of direct DNA-screening or monitoring of employees or applicants. See id.
38. See infra Part V (discussing OSHA and genetic testing).
39. See Rothstein, supra note 11, at 27 (pointing out that 42% of the companies
questioned in an OTA survey used a job applicant's health insurance risk as a factor in
deciding employability). This will unlikely serve as a successful argument for
employers because of legislation, such as the Americans with Disabilities Act, that limit
the type of medical testing employers are allowed to conduct on job applicants. See id.
at 39-62 (discussing the ADA and its effect on genetic testing).
40. See id. at 73 (noting that concern over this type of screening surfaced in the
1980s when it was documented that some employers were investigating genetic traits for
a link to occupational exposure).
41. See GENETIC MONITORING SURVEY, supra note 2, at 4 (listing "chromosomal
damage" or "increased molecular mutations" during employment as examples of genetic
material modifications).
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genetic -make-up.42 Reasons given to conduct genetic monitoring
include: identifying risks associated with certain toxins, targeting
work areas for increased safety, and identifying previously unknown
workplace toxins.43
Experts estimate that approximately three or four percent of all
newborns, and approximately fifteen to twenty percent of adults, have
congenital defects.' Additionally, each individual, regardless of any
visible signs of a genetic defect, carries approximately five to seven
lethal recessive genes.45 Some of these defects will have immediate
ramifications, while others only have future consequences or may have
no impact on the individual's health.4
Various illnesses, mental traits, and personality characteristics have
been linked to genetics.47 At present, however, most of the genetic
42. See id. It should also be noted that genetic monitoring can ascertain changes in
genetic material due to factors outside the workplace such as habits, age, and lifestyle.
See id.
43. See id.
44. See Deyerle, supra note 31, at 551 (noting that approximately one third of these
adults have defects that involve either a major medical or major cosmetic impact).
45. See id. The consequence of carrying a lethal recessive gene is that while the
individual himself will show no evidence of the defect, it is potentially hazardous for the
individual's offspring if he should mate with another person carrying the same recessive
gene. See RAYMOND F. ORAM, BIOLOGY LIVING SYSTEMS 144 (1983) (listing examples of
diseases caused by gene defects such as sickle cell anemia, which blocks the normal
transportation of oxygen to cells, and galactosemia, which may cause damage to the
nervous system).
46. See ORAM, supra note 45, at 144. For example, carriers of one Tay Sachs gene
will have no present symptoms. See BIGGS, supra note 22, at 344. The disease could
potentially manifest itself in the individual's offspring if he or she mated with another
Tay Sachs carrier. Someone carrying the gene for Huntington's disease, however, will
eventually develop the symptoms of this degenerative disease. It is not certain,
however, when the symptoms will appear. See id. at 37, 161. Other diseases, such as
phenylketonuria (PKU) and galactosemia can be treated successfully and will have little
or no impact on an individual's ability to work productively. See ORAM, supra note 45,
at 145.
47. See Rochelle Cooper Dreyfuss & Dorothy Nelkin, The Jurisprudence of Genetics,
45 VAND. L. REV. 313, 320 (1992). Some personality traits thought to be linked to
genetics include: mental illness, homosexuality, aggressive personality, job and
educational success, exhibitionism, stress, risk-taking behaviors, and shyness. See id.
Some examples of diseases linked to genetics include: sickle cell anemia, Bloom's
Syndrome, Tay-Sachs disease, breast cancer, cystic fibrosis, Huntington's disease, and
thalassemia. See generally Gostin, supra note 5, at 111 nn.9-11 (pointing out the fact
that specific genetic diseases are sometimes closely linked to particular ethnic or racial
groups such as African Americans, Ashkenazi Jews and Armenians); Karen H.
Rothenberg, Breast Cancer, The Genetic "Quick Fix" and the Jewish Community, 7
HEALTH MATRIX 97, 98 (1997) (noting that nearly one percent of sampled Eastern
European Jews contain a gene mutation that predisposes them to breast and ovarian
cancer); Katherine Brokaw, Comment, Genetic Screening in the Workplace and
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tests available are unreliable and often inconclusive.48 Often a genetic
test can only reveal the possibility that a person may develop a certain
disease in the future, but cannot tell whether the individual will actually
get the disease. 49  This is true because genetic tests are limited to
known genetic mutations associated with known diseases.50 Even
tests with high reliability cannot predict the time frame of disease onset
and eventual prognosis.5' The uncertainty associated with genetic tests
makes their use in employment decisions risky. Specifically, even
though individuals may never manifest symptoms during their lifetime,
mere possibilities of disease or a future genetic condition may cause
discrimination. The use of genetic testing is more frightening when
considering the history of genetic discrimination in the United States.52
B. The History of Genetic Discrimination in America
Genetic discrimination is defined as "discrimination against an
Employers' Liability, 23 COLUM. J.L. & Soc. PROBS., 317, 324 n.33 (1990) (charting
genetic traits and the primary group of people affected).
48. See Gostin, supra note 5, at 113 (explaining that medical technology does not
always provide an accurate assessment); Brokaw, supra note 47, at 325-26 (discussing
the inconclusive nature of scientific data linking traits to occupational disease).
49. See Gostin, supra note 5, at 114. For example, new genetic studies have linked
the gene BRCA1 to breast and ovarian cancer. See Rothenberg, supra note 47, at 98
(noting that this finding has prompted a clinical study to evaluate cancer risk in Eastern
Europe). Only about 5 to 10% of breast cancer cases, however, are linked to this gene.
See id. at 98-99. It is estimated that a woman from a high-risk family with the BRCAI
gene has an 85% chance of getting breast cancer. See id. at 99. This means that while
many women with the BRCA1 gene will develop breast cancer, many others will not.
An employer who does not wish to employ women who will contract breast cancer may
screen employees for BRCA1, but only at the cost of excluding many workers who may
never develop the disease.
50. See Gostin, supra note 5, at 113 (noting that, at present, genetic screening can
only detect 75% of cystic fibrosis chromosomes in the white population in the United
States).
51. See id. at 113-14. For example, the presence of Huntington's disease can be
detected with 99% accuracy. See Gin, supra note 3, at 1415 (pointing out that a test to
diagnose Huntington's disease may be administered at any time in a person's life and
will have no bearing in the accuracy of the diagnosis). While a positive test result
signals that an individual ultimately will get Huntington's disease, it is impossible to
predict when the disease will manifest itself and how quickly the person will become
debilitated. See Gostin, supra note 5, at 114 (attributing this inability to Huntington
disease's "multi-factorial" nature and to the fact that it is caused by a specific gene
mutation or marker). Thus, an individual with the genetic markers for Huntington's
disease may lead a long, productive life before the onset of the debilitating symptoms.
See Gin, supra note 3, at 1414-15 (estimating that the disease begins to surface at age
35).
52. History has shown that we are apt to overreact to small steps in genetic under-
standing, often with the result of discrimination against healthy, productive individuals.
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individual or a member of an individual's family solely on the basis of
that individual's genotype., 53  The first known use of genetic
discrimination occurred in the 1800s when Francis Galton published
his theory of eugenics 4.5  Eugenicists generally exaggerated the extent
to which human behavior and other traits could be traced to biology,
including the supposed connections between genetics and disease.
As early as 1938, J. B. S. Haldene introduced the idea of classifying
workers based on their genetic susceptibilities to disease.56 One of the
first reported cases of genetic susceptibility to a chemical agent or drug
was in the 1950s when some American soldiers in Korea experienced
hemolysis, (the destruction of red blood cells), after receiving the anti-
malaria drug primaquine.57 The hemolysis was attributed to the
soldiers' carrier status for glucose-6-phosphate dehydrogenase ("G-6-
PD") deficiency. 8
History most vividly illustrates discrimination "based on genotype"
through an examination of sterilization laws. During the early
twentieth century many states enacted immigration laws aimed at
"purifying and keeping pure blood in America."59 In 1907, Indiana
passed the United States' first sterilization law, forcing the sterilization
53. SUSAN MALAMATE VAZAKAS, GENETIC DISCRIMINATION AND THE AMERICANS WITH
DISABILITIES ACT 24 (1993) (citing Billings et al., supra note 7, at 477).
54. See Robert N. Proctor, Genomics and Eugenics: How Fair is the Comparison?, in
GENE MAPPING 57, 59 (George J. Annas & Sherman Elias eds., 1992). At the root of the
eugenics movement was the fear that "'racial poisons' (especially alcohol, tobacco,
narcotics, and syphilis) were threatening the health of the race; that the criminal,
mentally ill, and morally dissolute were outbreeding the more upstanding elements of
society." Id. at 60. One of the basic tenets of the eugenics movement was "biological
determinism--the idea that biology lies at the root of most human talents and
disabilities." Id.
55. See id. This movement was especially strong in Germany where the Nazi
government funded substantial research into the area of eugenics. See id. at 60.
56. See GENETIC MONITORING SURVEY, supra note 2, at 41 (noting Haldene's specific
suggestion to screen out potters who had "constitutions" that predisposed them for
bronchitis).
57. See id.
58. See id. (explaining that people with this trait or status are commonly found in
malaria-ridden areas, and it is also prevalent among African Americans and those with a
Mediterranean ancestry).
59. DANIEL J. KEVLES, IN THE NAME OF EUGENICS: GENETICS AND THE USE OF HUMAN
HEREDITY 97 (1985) (citing KENNETH LUDMERER, GENETICS AND AMERICAN SOCIETY 95-96
(1972)) (quoting Congressman Robert Allen of West Virginia). In addition to the states,
the federal government also passed biological laws aimed at keeping America's blood
"pure." See id. at 97. Specifically, in April 1924, President Calvin Coolidge signed the
Immigration Act, which severely limited the entrance of Europeans into the United
States through 1927. See id.
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of people suffering from many identified genetic disorders.6" Other
states followed suit over the next thirty years, generally targeting poor,
immigrant, and institutionalized individuals.6 The Eugenics Records
Office was established in 1910 to collect genetic data to advise people
on what constituted a fit marriage.62 In 1927, the Supreme Court
upheld these state-sanctioned sterilizations, and while this practice
today seems dubious, the Court has never specifically overruled this
decision.63
Several decades later, genetic screening again gained widespread
use. Specifically, in the 1970s, sickle cell anemia screening programs
began.64 These programs were aimed to expose poor health care
systems by identifying carriers of sickle cell anemia, a disease
common among African Americans.65 These programs were designed
to identify both healthy carriers 66 and diseased carriers of sickle cell
anemia. The programs affected healthy carriers of the gene because
scientists suggested that carriers of the gene might be hyper-
susceptible to certain workplace toxins such as benzene, lead,
60. See Proctor, supra note 54, at 61 (noting that Indiana's sterilization law was a
product of both American Eugenics and German racial hygiene).
61. See id. (noting that state laws preventing interracial marriages can also be linked
to genetic discrimination); see also Patricia A. King, The Past as Prologue: Race, Class,
and Gene Discrimination, in GENE MAPPING 94, 98 (George J. Annas & Sherman Elias
eds., 1992). The most comprehensive of these laws was passed in Iowa which allowed
sterilization of inmates in public institutions for crimes and other reasons including
"drug addition, sexual offenses, and epilepsy." KEVLES, supra note 59, at 100.
62. See KEVLES, supra note 59, at 53-55 (discussing a program designed to ensure that
marriages were appropriate based on a host of genetic criteria).
63. See Buck v. Bell, 274 U.S. 200 (1927) (per curiam). The Court upheld Virginia's
forced sterilization law for "mental defectives" and found that the law did not violate the
Fourteenth Amendment's Due Process or Equal Protection Clauses. See id. at 207. The
law purportedly provided sufficient procedural safeguards and only targeted those who
need treatment, which is done for their benefit. See id. at 207-08.
64. See Fox & Finesilver, supra note 12, at 75 (noting that screening was
"widespread" until 1972 when a federal law mandated that all such screening be
voluntary); see also King, supra note 61, at 98 (asserting that sickle cell anemia is a
genetic disorder that may occur with varying severity and occurs with greatest frequency
in people of African American descent).
65. See King, supra note 61, at 99 (noting that these programs began with the best
intentions, and were supported by African American leaders until they realized that such
measures "would be used to stereotype and disadvantage the very people they sought to
help.").
66. A healthy carrier refers to an individual who carries only one gene for the trait.
That person is said to be a sickle cell carrier. A person with sickle cell disease, on the
other hand, has two sickle cell genes. That person will manifest symptoms of the
condition. See GENETIC MONITORING SURVEY, supra note 2, at 42 (discussing sickle cell
traits and discrimination against carriers of sickle cell).
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cadmium, carbon monoxide, and cyanide. 67 Based on these sugges-
tions, employers began testing workers for the gene even though
available evidence and studies did not support this theory.68
Moreover, many state legislatures mandated sickle cell testing, leading
to further fear and discrimination.69 Inadequate measures to keep the
test results confidential led to stigmatization and discrimination against
sickle cell carriers in employment.7" Further, lack of knowledge and
understanding of the disease led to discrimination against many
carriers of the trait even though they would never develop sickle cell
disease. 7 To alleviate some of this stigma Congress passed the
National Sickle Cell Anemia Control Act.72 This Act withholds federal
funding from states unless sickle cell testing is voluntary.73
Our country's experience with sickle cell anemia testing suggests the
dangers inherent to genetic testing. Like the sickle cell tests of the
1970s, scientists today understand relatively little about the genetic
67. See Brokaw, supra note 47, at 323 (discussing concerns leading to testing for
sickle cell in the workplace).
68. See id. Du Pont pioneered one of the first testing programs for employees
exposed to benzene. See id. Du Pont, however, did not terminate workers who carried
the sickle cell gene. See id. Instead, it transferred these workers to comparable
positions where they would not come into contact with potentially dangerous toxins.
See id. Additionally, Dow Chemical piloted one of the first cytogenetic monitoring
programs in 1964. See GENETIC MONITORING SURVEY, supra note 2, at 44. Dow
conducted evaluations of employees exposed to epichlorohydrin and benzene. See id.
These tests were discontinued in 1977 because of questions about validity and reliability
of the results. See id. In the 1980s, Johnson and Johnson conducted cytogenetic
monitoring on employees exposed to ethylene oxide. See id. After six months these
tests were discontinued. See id.
69. See MARK A. ROTHSTEIN, MEDICAL SCREENING OF WORKERS 73 (1984). Thirty
states enacted legislation requiring African Americans to be tested for the sickle cell
trait. See id. Twenty-one of these states have not repealed their sickle cell screening
laws. See id. Some states required children be tested upon entering school while others
would only issue marriage licenses on a showing that the individuals had been tested.
See id. at 73-74.
70. See King, supra note 61, at 99 (discussing how the mandatory testing of African
Americans for sickle cell anemia negatively affected them because of the strong
possibility for stereotyping, discrimination, and general misinformation).
7 1. See id. For example, for many years the United States Air Force Academy refused
to allow African Americans with sickle cell trait to participate in pilot training based on
the mistaken belief that the low-oxygen environment associated with flight would cause
the carrier to undergo a sickling episode. See GENETIC MONITORING SURVEY, supra note
2, at 42-43. This policy was discontinued in 1981 even though it was determined in
1974 that there was insufficient evidence to link carrier status with sickling episodes in
low-oxygen environments. See id.
72. See National Sickle Cell Control Act, Pub. L. No. 92-294, 86 Stat. 136 (1972)
(codified as amended at 42 U.S.C. §300b (1976)).
73. See id. § 300b-2.
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conditions they are now able to identify. Today, we have the ability to
identify an increasing number of genes, and scientists are working to
correlate those genes with diseases and other human traits. In using
this knowledge, scientists must be cognizant of past discrimination and
avoid attaching any stigma to individuals because of the public's lack
of knowledge and understanding of genetic traits. Extending the
coverage of the ADA to persons with certain "inferior" genetic traits
may help combat potential abuses that accompany genetic testing.
III. THE AMERICANS WITH DIsABILITIES ACT
Generally, employment decisions are based on some type of
discrimination or differentiation. Employment applicants often are
discriminated against on the basis of their level of education, previous
experience, dress, mannerisms, and a host of other details. Congress,
however, has prohibited the use of certain factors to differentiate
among applicants. Title VII, for example, prevents discrimination
based on race, religion, nationality, color, and sex.74 More recently,
Congress passed the ADA to discourage discrimination against
individuals based on their disabilities.75 The ADA potentially provides
employees the greatest protection against genetic discrimination.76
A. Covered Entities Under the ADA
Title I of the ADA prohibits employment discrimination on the basis
of disability,77 by employers with fifteen or more employees.78 The
74. See 42 U.S.C. § 2000e-2(a) (1964) ("It shall be an unlawful employment practice
for an employer . . . to discriminate against any individual . . .because of such
individual's race, color, religion, sex or national origin."); see also infra Part IV
(analyzing Title VII and genetic discrimination).
75. The ADA was passed in 1990 and became effective in 1992. See 42 U.S.C. §
12111 (1990) ("No covered entity shall discriminate against a qualified individual with a
disability because of the disability of such individual in regard to ... employment.").
76. See Thomas H. Christopher & Charles M. Rice, The Americans With Disabilities
Act: An Overview of the Employment Provisions, 33 S. TEX. L. REV. 759, 760 (1992)
(quoting 136 CONG. REC. H2430 (daily ed. May 17, 1990) (statement of Rep. Conte))
(describing the ADA as the "declaration of independence" for millions of disabled
Americans).
77. 42 U.S.C. § 12112(a). The ADA provides that "[n]o covered entity shall
discriminate against a qualified individual with a disability because of the disability of
such an individual in regard to job application procedures, the hiring, advancement, or
discharge of employees, employee compensation, job training, and other terms,
conditions, and privileges of employment." Id.
78. See id. § 12111(5)(A); 29 C.F.R. § 1630.2(e)(1) (1998). Employer, as defined in
the ADA excludes "(i) [t]he United States, a corporation wholly owned by the
government of the United States, or an Indian Tribe; or (ii) [a] bona fide private
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ADA also includes provisions that apply to public services performed
by governmental entities;7 9 public accommodations operated by private
entities;8° and telecommunications networks.
81
B. Medical Testing Under the ADA
The medical testing provisions within the ADA pose the first
obstacle to employers who seek to perform genetic testing on job
applicants.82 While the ADA does not specifically define a medical
test,83 it was enacted to discourage the use of medical test results in the
hiring process regardless of whether a revealed condition would have
any impact on the applicant's ability to perform the job.84 Further,
while there is no precise meaning of a medical test it cannot seriously
be argued that a genetic test is not a medical test under the ADA. The
ADA addresses medical testing in three separate stages of the
membership club ...that is exempt from taxation under section 501(c) of the [Internal
Revenue Code of 1986]." Id.
79. See id. §§ 12131-12165. "[N]o qualified individual with a disability shall, by
reason of such disability, be excluded from participation in or be denied the benefits of
the services, programs, or activities of a public entity, or be subjected to discrimination
by any public entity." Id. § 12132.
80. See id. §§ 12181-12189. "No individual shall be discriminated against on the
basis of disability in the full and equal enjoyment of the goods, services, facilities,
privileges, advantages, or accommodations of any place of public accommodation ..
Id. § 12182(a).
81. See 47 U.S.C. §§ 225, 611 (1994 & Supp. 1996). "[Tlhe Commission shall
ensure that interstate and intrastate telecommunications relay services are available, to
the extent possible and in the most efficient manner, to hearing-impaired and speech-
impaired individuals ..... Id. § 225(b)(1).
82. See 42 U.S.C. § 12112(d)(1) ("The prohibition against discrimination ...shall
include medical examinations and inquiries."). This section was enacted to discourage
the prevalent practice of medically testing job applicants and making job offers based
on the outcome of those tests regardless of whether the medical conditions revealed
would have any impact on the applicant's ability to perform the job in question. See
Christopher & Rice, supra note 76, at 790.
83. The definition of a medical exam has been found to encompass psychological
tests. See Barnes v. Cochran, 944 F. Supp. 897 (S.D. Fla. 1966), aff'd, 130 F.3d 443
(11th Cir. 1997); see also Equal Employment Opportunity Commision, ADA
Enforcement Guidance: Pre-Employment Disability-Related Questions and Medical
Examinations, BNA-DLR, Oct. 10, 1995, at 8, available in WESTLAW, 1995 DLR 196
d46 ("A 'Medical Examination' is a procedure or test that seeks information about an
individual's physical or mental impairments or health.").
84. See Christopher & Rice, supra note 76, at 790 (discussing actions permitted and
prohibited by the employer under the ADA). A survey conducted by the Office of
Technology Assessment in 1989 (before the ADA was enacted) reported that 49% of
companies surveyed required pre-employment health examinations of all job applicants
and an additional 10% required health examinations for most job applicants. See
MEDICAL MONITORING SURVEY, supra note 6, at 4.
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employment relationship: pre-employment," after a job offer is madebut before it is finalized,86 and during employment.87
1. Pre-employment Testing
Under the ADA, an employer cannot conduct pre-offer medical
examinations on an applicant.88 In addition, the employer is prohibited
from asking an applicant about the existence or severity of any
disability.89 The employer may, however, inquire into the ability of
the applicant to perform job-related functions. 90 It is likely, however,
85. See 42 U.S.C. § 12112(d)(2)(A) (1990) ("[A] covered entity shall not conduct a
medical examination or make inquiries of a job applicant as to whether such applicant is
an individual with a disability or as to the nature or severity of such disability."); 29
C.F.R. § 1630.14 (a) (1998) ("A covered entity may make pre-employment inquiries
into the ability of an applicant to perform job-related functions .... ").
86. See 42 U.S.C. § 12112(d)(2)(B) ("A covered entity may make pre-employment
inquiries into the ability of an applicant to perform job-related functions.); 29 C.F.R. §
1630.14(b) (stating that an employer may condition an offer of employment on the
results of a medical exam after the offer is made).
87. See 42 U.S.C. § 12112(d)(3)(A) (allowing medical testing upon acceptance of an
offer if all employees are tested as such); 29 C.F.R. § 1630.14(c) ("A covered entity may
require a medical examination ... of an employee that is job-related and consistent with
business necessity.").
88. See 42 U.S.C. § 12112(d)(2)(A). This is particularly significant in light of a
study indicating that, prior to the passage of the ADA, 87.8% of large plants (those with
more than 500 workers) and 56.4% of medium plants (those with 100-499 workers)
required medical examinations prior to employment. See Jennifer M. Ratcliffe et al.,
The Prevalence of Screening in Industry: Report from the National Institute for
Occupational Safety and Health, National Occupational Hazard Survey, 28 J.
OCCUPATIONAL MED. 906, 907-08 (1986); see also Rothstein, supra note 11, at 52-53
(stating that at the time of the article (1992), nearly 90% of workers at larger plants and
over 50% of workers at smaller plants were subjected to pre-employment medical
examinations).
89. See 42 U.S.C. § 12112(d)(2)(A). The ADA does recognize, however, the right of
employers to ask questions about disabilities in limited situations. See Christopher &
Rice, supra note 76, at 791-92 (discussing legitimate reasons for an employer to invite a
job applicant to identify his disabilities). The ADA's legislative history indicates that
an employer may inquire as to disabilities and their extent if the employer is taking
affirmative action to correct past discrimination or in order to overcome the effect of
conditions that previously prevented the employer from hiring disabled individuals. See
id. In requesting this information the employer must inform the applicant that it is for
remedial or affirmative action purposes, it is entirely voluntary, and that the
information will be kept confidential and will not be used to discriminate against the
applicant. See id. at 792.
90. See 42 U.S.C. § 12112(d)(2)(B) ("A covered entity may make pre-employment
inquiries into the ability of an applicant to perform job-related functions."). In fact,
EEOC guidelines suggest that an employer may list the essential job functions and ask
an applicant whether he or she is capable of performing those functions. See 29 C.F.R.
§ 1630.14(a). The Code of Federal Regulations states that: "A covered entity may make
pre-employment inquiries into the ability of an applicant to perform job-related
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that most genetic disorders do not present symptoms that affect job-
related functions. 91 Only testing reveals the existence of a genetic
marker in the individual, therefore, the individual who is unaware of
his or her genetic condition cannot answer questions about the
unknown. Even if an individual had knowledge of a genetic disorder,
an inquiry into whether an individual could perform basic job
functions would be irrelevant in most cases of latent genetic disorders
because the disorder would have no discernible effect on the
employee's ability to perform the job at the present moment.
A second pre-employment issue arises after the offer of employment
is extended. Such an offer is not always permanent. Typically, once
the offer of employment is made, that offer may be conditioned on the
outcome of a medical examination.92 The ADA provides that "[a]
covered entity may require a medical examination after an offer of
employment has been made to a job applicant and prior to the
commencement of the employment duties of such applicant, and may
condition an offer of employment on the results of such
examination." 93 These examinations must satisfy three requirements.
First, an employer must test all entering employees regardless of
disability. 94 Second, the information collected must be maintained on
separate forms and in a separate medical file and treated as
confidential.95 Third, the results of the medical examination may be
functions and/or may ask an applicant to describe or to demonstrate how, with or
without reasonable accommodation, the applicant will be able to perform job-related
functions." Id.
91. Often these genetic disorders will manifest no symptoms at all during the
individual's entire life span. For example, the carrier of a single recessive gene for Tay
Sachs Disease of Galaetosemia will have no symptoms of the disease. See ORAM, supra
note 45, at 161.
92. In some cases the law may even require employers to perform medical
examinations before allowing a worker to begin employment. For example, OSHA
requires medical examinations of employees who will be exposed to certain toxins. See
infra note 199 (providing examples of circumstances when testing is required).
93. 42 U.S.C. § 12112(d)(3); see also 29 C.F.R. § 1630.14(b) ("A covered entity
may require a medical examination ... after making an offer of employment ... and may
condition an offer of employment on the results of such examination.").
94. See 42 U.S.C. § 12112(d)(3)A); 29 C.F.R. § 1630.14(b) (conditioning medical
examinations on the fact that "all entering employees in the same category are subjected
to such an examination . . . regardless of disability").
95. See 42 U.S.C. § 12112(d)(3)(B); 29 C.F.R. § 1630.14(b)(1). There are
exceptions to the confidentiality rule for: (1) supervisors and managers who need to be
informed of any required restrictions on the work or duties of employees and any
necessary accommodations; (2) first aid and safety personnel who may be informed when
the disabled individual might require emergency medical treatment; and (3) government
officials investigating compliance with the Act. See 29 C.F.R. § 1630.14(b)(1)(i-iii).
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used only "in accordance with this sub-chapter." 96 This section,
however, does not restrict the purpose behind the test, so an employer
may theoretically test for any medical condition. In fact, the relevant
EEOC regulation states that "[m]edical examinations conducted in
accordance with this section do not have to be job-related and
consistent with business necessity."97 Yet, the third requirement under
the ADA provides protection against discrimination,98 which means
that while the employer can test for anything, he cannot then use the
test results to discriminate against the employee or applicant in
violation of the ADA. 99
2. Testing During Employment
An individual's status as an employee restricts the type of medical
examinations an employer can require throughout the duration of
employment. °° Medical examinations of employees must be "job-
related and consistent with business necessity."'0 1 In addition, an
employer can conduct voluntary medical examinations, including those
that accompany an employee health program. 1 2 The employer may
96. 42 U.S.C. § 12112(d)(3)(C).
97. 29 C.F.R. § 1630.14(b)(3).
98. See 42 U.S.C. § 12112(d)(3)(C); see also 29 C.F.R. §1630.14(b)(3) (stating that
"if certain criteria are used to screen out an employee or employees with disabilities as a
result of such an examination or inquiry, the exclusionary criteria must be job-related
and consistent with business necessity, and performance of the essential job functions
cannot be accomplished with reasonable accommodation").
99. See 42 U.S.C. § 12112(b)(6) (providing that an employer cannot use
"employment tests or other selection criteria that screen out or tend to screen out an
individual with a disability or a class of individuals with disabilities unless the standard,
test or other selection criteria, as used by the covered entity, is shown to be job-related
for the position in question and is consistent with business necessity") (emphasis
added).
100. See id. § 12112(d)(4)(A) ("A covered entity shall not require a medical
examination and shall not make inquiries of an employee as to whether such employee is
an individual with a disability .... "). However, the Code of Federal Regulations makes
clear that "[a] covered entity may require a medical examination ... of an employee that
is job-related and consistent with business necessity." 29 C.F.R. § 1630.14(c).
101. 42 U.S.C. § 12112(d)(4)(A); 29 C.F.R. § 1630.14(c). These sections may
interact with other laws such as OSHA that require employers to perform medical tests on
workers exposed to certain toxins.
102. See 42 U.S.C. § 12112(d)(4)(B). The statute states, "[a] covered entity may
conduct voluntary medical examinations, including voluntary medical histories, which
are part of an employee health program." Id.; see also 29 C.F.R. § 1630.14(d) (stating
"[a] covered entity may conduct voluntary medical examinations and activities,
including voluntary medical histories, which are part of an employee health program").
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also make inquiries into "the ability of an employee to perform job-
related functions.' 0 3
Genetic screening would theoretically be legal if it were "directly
related to qualifications for doing the task or if necessary for employee
safety."' 14 Job-relatedness, however, generally applies only to the
employee's present capability to perform the job. 105 It is doubtful that
most genetic conditions, especially asymptomatic ones, would rise to
the level of job-relatedness or business necessity so as to allow an
employer to discriminate against applicants with the condition. An
asymptomatic genetic disorder might have future ramifications, but
would not affect the individual's present ability to perform his or her
job. An employer could rarely justify genetic screening based on job-
relatedness in order to overcome the ADA's protection.
Overall, with the exception of medical tests required by OSHA or
other federal regulations, employers are most likely to use genetic
testing after a conditional job offer is made, but before the offer is
finalized.'06 Employers have a right to conduct medical or genetic tests
at this stage in the hiring process. The issue becomes whether the
employer can use the information gained from these tests to
discriminate against workers with genetic defects.
C. Establishing an ADA Claim
In order to establish a discrimination claim under the ADA, an
applicant or employee must show that he (1) has a disability, (2) was
otherwise qualified for the employment or benefit in question, and (3)
was excluded from the employment or benefit because of the
103. 42 U.S.C. § 12112(d)(4)(B); see also 29 C.F.R. § 1630.14(c).
104. Charles B. Gurd, Whether a Genetic Defect is a Disability Under the Americans
with Disabilities Act: Preventing Genetic Discrimination by Employers, 1 ANNALS
HEALTH L. 107, 110 (1992) (quoting Peter T. Rowley, Genetic Discrimination: Rights
and Responsibilities of Tester and Testee: Summary of a Workshop Sponsored by the
Social Issues Committee, American Society for Human Genetics, November 2, 1986, 43
AM. J. HUM. GENETICS 105 (1988)) (analyzing whether genetic defects qualify as
disabilities under the ADA).
105. See 29 C.F.R. § 1630.10 (noting that tests must be related to the position in
question); see also Gurd, supra note 104, at 110 (suggesting that refusal to employ a
disabled applicant should only be allowed where the applicant is presently unable to
perform the job).
106. See MEDICAL MONITORING SURVEY, supra note 6, at 4. While few employers are
currently using genetic screening, an OTA survey found that approximately 50% of
responding personnel officers said they would approve of health exams of applicants for
workplace susceptibilities. See id.
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disability.' °7 Whether an individual is affected by a disability, as
defined under the ADA, is generally the most controversial issue in a
genetic discrimination claim. A plaintiff can establish a disability
under the ADA three different ways. A disability is defined as "(A) a
physical or mental impairment that substantially limits one or more of
the major life activities ... ; (B) a record of such an impairment; or
(C) being regarded as having such an impairrient."'0 8
1. Physical or Mental Impairment Substantially Limiting One or More
Major Life Activities
The EEOC has defined a physical impairment as "[a]ny
physiological disorder, or condition, cosmetic disfigurement, or
anatomical loss affecting one or more of the following body systems:
neurological, musculoskeletal, special sense organs, respiratory
(including speech organs), cardiovascular, reproductive, digestive,
genito-urinary, hemic and lymphatic, skin and endocrine."'0 9 Mental
impairments encompass "[a]ny mental or psychological disorder, such
as mental retardation, organic brain syndrome, emotional or mental
illness, and specific learning disabilities."11 0 Not all impairments
receive protection under the ADA. In order to receive protection, the
impairment must substantially limit a major life function. Whether a
disability is "substantially limiting" depends on the nature and severity
of the impairment, the duration or expected duration of the impairment,
and the permanent or long-term impact of the impairment."'
Additionally, to invoke coverage under this prong, the impairment
must affect "a major life activity." The EEOC regulations provide that
a "major life activity" includes things such as "caring for oneself,
performing manual tasks, walking, seeing, hearing, speaking,
breathing, learning, and working."'12
107. See 42 U.S.C. § 12112(a) ("No covered entity shall discriminate against a
qualified individual with a disability because of the disability of such individual . . . [in]
employment.").
108. Id. § 12102(2).
109. 29 C.F.R. § 1630.2(h)(1).
110. Id. § 1630.2(h)(2).
111. See 29 C.F.R. § 1630.2(j)(2). A person with a short-term injury, such as a
broken leg, would not qualify as having a substantially limiting impairment; nor would
someone with a temporary illness such as influenza or pneumonia. See Christopher &
Rice, supra note 76, at 769 (providing examples of substantially limiting impairments).
112. 29 C.F.R. § 1630.2(i) (emphasis added). The EEOC has added sitting, standing,
lifting, reaching, reading, thinking, concentrating, and interacting with others as major
life functions. See 29 C.F.R. pt. 1630 App. § 1630.2(i); EEOC Disability Guidance §
902.3(b); EEOC Technical Assistance § 2.2(a)(ii). The United States Supreme Court
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Most genetic disorders do not exhibit present symptoms that would
qualify as "substantially limiting a major life function. '' 13
Specifically, subsection (A) of the ADA appears to omit three major
categories of genetic disorders. First, this section would not apply to
an individual whose genetic defect has not yet become a physical
disorder, but may become one in the future." 4 Second, this section
does not protect an individual who may be a carrier for a disease that
will never manifest itself in the individual, but may appear in his or her
offspring." 5 Finally, the section does not protect a person who may
have a disabling disorder that is under treatment, but manifests no
physical symptoms. 116 Employees in any of these three categories
would not be protected under section (A) of the ADA because their
"disability" does not currently affect "a major life function.""' 7 If an
recently added reproduction to the list of major life functions and hinted that sexual
relations were a major life function as well. See Bragdon v. Abbott, 118 S. Ct. 2196,
2205 (1998).
113. For example, an individual with sickle cell trait will never develop symptoms.
Additionally, a person who is identified as having a genetically higher risk of breast
cancer, but without the disease, would not have a disability that presently substantially
limits any major life function.
114. For example, the gene for Huntington's disease is carried by a person for his or
her entire life, but the disease may not cause physical symptoms for years. None of the
listed major life activities, therefore, are presently limited. See Gin, supra note 3, at
1414-15 (providing a description of the physical manifestations of Huntington's
disease).
115. For example, Tay Sachs disease, a disease caused by a recessive gene, usually
results in death by age three due to failure of the nervous system to properly develop.
Whether a person is a carrier for Tay Sachs is detectable through a simple blood test.
The carrier, however, will not manifest the disease. The only danger is to the
individual's offspring if he or she should have a child with another Tay Sachs carrier.
See ORAM, supra note 45, at 161 (discussing the effects of Tay Sachs disease on both
carriers and those who exhibit its symptoms).
116. See id. (noting that PKU, a disease caused by a recessive gene, if left untreated
will result in severe mental retardation, can be successfully treated through diet). Note,
however, that some courts have determined that these individuals would qualify as
"disabled" under the ADA because they do not take into account mitigating measures, but
rather look to the individual in an unmedicated state. See, e.g., Matczak v. Frankford
Candy & Chocolate Co., 136 F.3d 933, 937 (3d Cir. 1997) (involving a former epileptic
employee who brought a suit against his former employer for violating the ADA when
the employee was dismissed due to his condition).
117. See supra note 112 and accompanying text (describing "a major life activity"
under section (A) of the ADA). For a carrier of an inheritable disease such as Tay Sachs it
can be argued that reproduction is a major life function that is substantially impaired.
This argument, however, has generally been unsuccessful even in the context of AIDS
where the risk of passing on the disease to one's offspring is much greater than for
carriers of Tay Sachs, and the risk is associated with all partners rather than other
carriers of the trait. See Runnebaum v. NationsBank of Md., 123 F.3d 156, 172 (4th
Cir. 1997) (finding that AIDS does not substantially limit procreation, and intimate
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employee did have a disability and exhibited symptoms that limited a
major life function, he would be covered under this section whether
the root of that disability was a genetic defect or another medical
condition.
2. Record of Impairment
The ADA's second classification of disability involves an
individual's record of a substantially limiting impairment." 8 Through
this requirement, Congress sought to protect individuals who have
recovered from a disabling condition," 9 and individuals who never
had a disability, but were misclassified or misdiagnosed in the past. 20
This prong may have ramifications for individuals who incorrectly test
positive for a genetic disorder, an outcome that is highly likely given
the inaccuracies and inconsistencies of current genetic tests.
3. Regarded as Having an Impairment
The third prong, subsection (C), is the employee's greatest
protection against genetic discrimination. This prong includes "being
regarded as having such an [substantially limiting] impairment."' 2'
Subsection (C) recognizes that "society's accumulated myths and fears
about disability and disease are as handicapping as are the physical
limitations that flow from actual impairment.' ' 122  To determine
sexual conduct does not interfere with a major life function under the ADA); Cortes v.
McDonald's Corp., 955 F. Supp. 541, 546 (E.D.N.C. 1996) (finding that procreation
was not a major life function under the ADA); Zatarain v. WDSU-Television, Inc., 881 F.
Supp. 240, 243 (E.D. La 1995) (finding that reproduction was not a major life function),
aff'd, 79 F.3d 1143 (5th Cir. 1996). But see Doe v. District of Columbia, 796 F. Supp.
559, 568 (D.C. Cir. 1992) (finding that an HIV-positive firefighter was substantially
impaired in the major life functions of "procreation, sexual contact, and normal social
relationships").
118. See supra note 108 and accompanying text (providing the definition of a
disability under the ADA).
119. See Christopher & Rice, supra note 76, at 770 (citing S. REP. No. 116, 101st
Cong., 1st Sess. 23 (1989); H.R. REP. NO. 485, 101st Cong., 2d Sess., pt. 2, at 52
(1990)).
120. See 29 C.F.R. § 1630.2(k) (1998) ("Has a record of such impairment means has
a history of, or has been misclassified as having, a mental or physical impairment.").
121. See 42 U.S.C. § 12102(2) (1990).
122. School Bd. of Nassau County v. Arline, 480 U.S. 273, 284 (1987) (finding that
the dismissal of a teacher based on her susceptibility to tuberculosis violated the
Rehabilitation Act of 1983. Even though she was not impaired she was being
discriminated against because of a perceived impairment). The category of perceived
impairment has been used to protect individuals with severe burns, asymptomatic back
abnormalities, and high blood pressure. See Christopher & Rice, supra note 76, at 771-
72 (discussing examples of being "regarded as having an impairment" under the ADA).
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whether an employee is regarded as having a disability the court must
"examine the employer's perception and treatment of the charging
party."' 123 Unlike the other disability categories, this section is based
on the employer's perceptions, not the existence of a true disability or
even the individual's own perception of himself or herself as disabled.
Individuals with asymptomatic genetic disorders, therefore, would
most likely be covered by this section because employers would be
discriminating based on the presence of a genetic anomaly, not on the
employee's inability to perform. 
124
D. EEOC Guidelines
The Equal Employment Opportunity Commission must develop
standards and guidelines to implement federal laws that deal with
equality in employment. The EEOC has failed to provide clear
direction regarding genetic classification as a form of discrimination
under the ADA. In its first statement on the subject, the EEOC refused
to include genetic discrimination as a violation of the ADA. 25 In
1991, the Acting Director of Communications and Legislative Affairs
for the EEOC wrote an opinion letter stating that the ADA does not
prohibit genetic discrimination "until the condition 'exists' and the
individual is symptomatic." 126 This letter, however, was only an
The Rehabilitation Act of 1983 was a precursor to the ADA that only applied to
government employees. While the Rehabilitation Act has not been repealed, it is not
dealt with in this paper because of its similarity to the ADA, which is discussed in-depth.
123. EEOC Compl. Man. (BNA) § 902.8(a) (1995).
124. But see OR. REV. STAT. § 659.705(e) (Supp. 1998) (stating the legislative
finding that "[c]urrent legal protections for medical information, tissue samples and
DNA samples are inadequate to protect genetic privacy"); Frank R. Emmerich, Jr.,
Employee Terminated/Cause of Action Dismissed: The Americans with Disabilities Act
Provides No Haven for Employees Hypersusceptible to Genetic Illness, 4 J. INDIVIDUAL
EMPL. RIGHTS 185 (1995-96) (suggesting that an employee will not be able to challenge
genetic discrimination under the ADA because a genetically hyper-susceptible employee
does not have a "disability" within the meaning of the ADA); Gostin, supra note 5, at
142-43 (suggesting that the ADA fails to adequately protect against genetic
discrimination because of its silence about discrimination based on the potential for
future disability); Rothstein, supra note 11, at 83-84 (concluding that the ADA does not
provide sufficient protection to employees against genetic discrimination).
125. See Rothstein, supra note 11, at 45 (citing Letter from Ronnie Blumenthal,
Acting Director of Communications and Legislative Affairs, EEOC, to Rep. Bob Wise,
Chairman, House Subcommittee on Government Information, Justice and Agriculture
(Nov. 22, 1991)); see infra note 126 (providing text of letter in which the Acting
Director of Communications and Legislative Affairs for the EEOC stated that the ADA
does not cover genetic discrimination).
126. Rothstein, supra note 11, at 45 (citing Letter from Ronnie Blumenthal, Acting
Director of Communications and Legislative Affairs, EEOC, to Rep. Bob Wise,
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informal statement given to the news media with little lasting authority.
In its first formally published statement on the subject, the EEOC
reversed this position and included genetic discrimination under the
auspices of the ADA. The EEOC compliance manual now includes a
short statement that addresses the "being regarded as having a
disability" prong of the ADA's disability test. This statement provides
that the ADA:
[A]pplies to individuals who are subjected to discrimination on
the basis of genetic information relating to illness, disease, or
other disorders. Covered entities that discriminate against
individuals on the basis of such genetic information are
regarding the individuals as having impairments that
substantially limit a major life activity. Those individuals,
therefore, are covered by the third part of the definition of
"disability." 127
This more recent statement better illustrates the modern ADA inter-
pretation. If the intent behind the law is to protect individuals from the
myths and fears of society, it should apply to individuals with genetic
disorders as well as other types of asymptomatic diseases.
E. An Employer's Defense Under the ADA
The ADA does not per se prevent discrimination against disabled
individuals. The interests of the worker are balanced against the
interests of the employer to determine whether the employer can
discriminate against a specific worker or applicant. One way for an
employer to circumvent the ADA protections is to establish that making
Chairman, House Subcommittee on Government Information, Justice and Agriculture
(Nov. 22, 1991)). The letter stated that:
Everyone has hereditary genetic characteristics that predispose them to the
onset of particular illnesses or diseases that could become disabilities under
the ADA. If your grandmother had heart disease, you may have a
predisposition to heart disease . . . .However, the presence of these genetic
characteristics does not indicate that an individual has an impairment or a
record of an impairment, or necessarily that the individual may develop an
impairment in the future. Consequently, the Commission determined that a
characteristic predisposition to illness, like that revealed in a family history,
is not an impairment covered by the ADA.
Id. at 46-47. The letter also stated that genetic issues "are unique and outside the
Commission's expertise, [and therefore] they should be resolved by means of
legislation, not by agency regulation." Id. ; see also Emmerich, supra note 124, at 200
(explaining that the EEOC's interpretation of the ADA as described in the November 22,
1991 letter prevented individuals with genetic disorders from receiving ADA protection
from genetic discrimination).
127. EEOC Compl. Man. (BNA) § 902.8(a) (1995).
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accommodations for the disabled worker would create an "undue
hardship" on the employer. 128
1. Undue Hardship
The ADA defines an "undue hardship" as "an action requiring
significant difficulty or expense."' 129 In order to determine whether the
proposed accommodation would constitute an undue hardship, the
employee's interests are balanced against those of the employer. 3 ° In
some instances an employer must expend substantial sums of money
to accommodate a disabled employee if it cannot establish an undue
hardship. '31
It would be difficult for an employer to establish that it could not
reasonably accommodate a hyper-susceptible worker without an undue
hardship. Asymptomatic carriers of genetic diseases do not need
workplace modifications and it is doubtful the employer can hide
behind fears of the need for future modifications. Failure to
reasonably accommodate based on the economic costs of future illness
128. See 42 U.S.C. § 12112(b)(5)(A) (1990). The statute states that a reasonable
accommodation must be provided to an otherwise qualified but disabled individual unless
the employer "can demonstrate that the accommodation would impose an undue hardship
on the operation of the business" of the employer. Id.
129. Id. § 12111 (10)(A). The Code of Federal Regulations further defines undue
hardship as referring to "any accommodation that would be unduly costly, extensive,
substantial, or disruptive, or that would fundamentally alter the nature or operation of
the business." 29 C.F.R. § 1630.2(p) app. at 353-54 (1998).
130. Courts consider several factors in balancing an employee's interest against the
expense to an employer. The factors to be considered include: (1) the nature and cost of
the modifications; (2) the overall financial resources of the facility; (3) the number of
employees at the facility; (4) the overall financial resources of the entire company; (5)
the type of operations of the company; and (6) the impact the accommodations would
have on the operations at the facility. See 29 C.F.R. § 1630.2(p)(2). The EEOC has not
given guidelines as to how each of these factors should be weighted in determining
whether accommodating a disabled worker would be an undue hardship.
131. See 29 C.F.R. § 1630.2(p) app. at 353-54 (stating "[i]n other cases,
consideration of the financial resources of the employer ...may be inappropriate
because it may not give an accurate picture of the financial resources available to the
particular facility that will actually be required to provide the accommodation"). For
example, a large company may be required to provide costly accommodations to a
worker at a small facility based on its overall resources. If that accommodation,
however, would result in the closing of the small plant due to unprofitability, then the
modification might not be required even though the overall company could afford it. See
Christopher & Rice, supra note 76, at 782-84 (citing H.R. REP. No. 485, 101st Cong.
2d Sess., pt. 2, at 69-70 (1990)) (explaining that "the overall size of the employer may
be decisive in some instances, but the local situation may be the determinative factor in
others").
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has never successfully been raised by an employer.132 The employer,
however, may be able to reduce the effect of future costs by limiting
the type of medical insurance available to the employees. 33
Employers have alleged that the rising insurance cost and other health
care benefits create a sufficient "undue hardship," but this too is likely
to fail. 13
4
Because there is no case law135 and few regulations address genetic
disorders and discrimination under the ADA, observers must compare
genetic discrimination with other types of medical discrimination.
Genetic discrimination is best analogized to discrimination against
asymptomatic individuals with Human Immunodeficiency Virus
("HIV").
F. HV as a Disability Under the ADA-A General Comparison
Like many genetic disorders, HIV is a precursor to a more serious
illness: Acquired Immune Deficiency Syndrome ("AIDS"). A simple
blood test can identify HIV. Testing positive for HIV means that there
is a high likelihood the individual will contract AIDS in the future.
132. See Shawn v. Legs Co. Ltd. Partnership, No. 89-23216, 1989 WL 258819 (N.Y.
Sup. Ct. Sept. 11, 1989) (refusing to allow employer to use speculation concerning
future health problems to discriminate against an employee).
133. The limitation, however, would have to apply to all employees. Providing
different insurance to different employees based on genetic make-up would run afoul of
the ADA. See also JAMES G. FRIERSON, EMPLOYER'S GUIDE TO THE AMERICANS WITH
DISABILITIES ACT 222 (2d ed.1995) (noting that the legality of insurance caps for AIDS
under the ADA has not yet been decided).
134. See id. at 221 (discussing doubt that excessive insurance costs can be used by
employers to justify discrimination against employees or applicants with AIDS or HIV).
But see Emmerich, supra note 124, at 210 (arguing that when considering health care
costs and the costs of training an employee who is not likely to provide long years of
service, it would be possible that the employer, especially a smaller one, would be
protected from the ADA provisions requiring accommodations).
In addition, employers who self-insure may be able to cut health costs by eliminating
insurance coverage for specific genetic diseases. Because § 501 of ERISA protects the
self-insured from broad ERISA legislation, the self-insuring employer may be able to
side-step the ADA by eliminating coverage for specific illnesses. For example, in
McGann v. H & H Music Company, 946 F.2d 401 (5th Cir. 1991), an employer who
discovered an employee was diagnosed with HIV reduced the health benefits available for
AIDS from $1 million to $5,000. This action was upheld by the Fifth Circuit, even
though it had an adverse effect on the disabled worker. See McGann, 946 F.2d at 408;
see also Owens v. Storehouse, Inc., 984 F.2d 394 (lth Cir. 1993) (upholding an
employer's right to modify its insurance plan to include a $25,000 lifetime cap for
AIDS-related claims).
135. See Fox, supra note 13 (discussing Norman-Bloodsaw v. Lawrence Berkeley
Lab., 135 F.3d 1260 (9th Cir. 1998), which is a currently pending case concerning an
employer's use of genetic testing).
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In Bragdon v. Abbott,'36 the Supreme Court recently held that an
individual with asymptomatic HIV is disabled under the ADA.3 7 The
Court found that even asymptomatic HIV was a physical impairment
because the virus is still thriving within the individual's lymph nodes
although relatively few symptoms are exhibited during this stage.1
38
The Court also pointed to the fact that an HIV infection "causes
immediate abnormalities in a person's blood.' ' 139 Like any other
medical test, the employer could arguably include an HIV test as part
of a post-offer medical exam, but would be limited on how it could use
that information.'" Like any other disability, the ADA only permits an
employer to rescind a job offer based on a positive test result if the
applicant is unable to perform the job'4 ' or is a threat to the safety or
health of others. 42 A direct threat may arguably exist in those few
jobs where the employee is likely to come in contact with bodily fluid
from other individuals. Even here, however, the Center for Disease
Control does not recommend mandatory HIV testing. 14 In addition, a
136. Bragdon v. Abbot, 118 S. Ct. 2196 (1998).
137. See id. at 2204.
138. See id. ("The HIV infection must be regarded as a physiological disorder with a
constant and detrimental effect on the infected person's hemic and lymphatic systems
from the moment of infection.").
139. Id.
140. Its use as part of a post-offer medical exam is permitted if not prohibited by
state law. See, ME. REV. STAT. ANN. tit. 5, § 19204-B (West Supp. 1998) (prohibiting
an employer from requiring an HIV test for an employee or prospective employee as a
condition of employment); VT. STAT. ANN. tit. 3, § 961 (1995), (stating it is an unfair
employment practice for an employer to condition future or continuing employment on
testing for HIV); WIS. STAT. ANN. § 103.15 (1997) (providing that no employer may, as
a condition of employment, require any employee or prospective employee to submit to
an HIV test).
141. See 42 U.S.C. § 12113(a) (1990) (explaining that standards which "tend to
screen out or otherwise deny a job or benefit to an individual with a disability" may be a
defense to discrimination if such standards "ha[ve] been shown to be job-related and
consistent with business necessity, and such performance cannot be accomplished by
reasonable accommodation"); see also 29 C.F.R. § 1630.14(b)(3) (1998) (stating that
exclusionary criteria is permissible where such criteria is "job-related and consistent
with business necessity, and performance of the essential job functions cannot be
accomplished with reasonable accommodation").
142. See 42 U.S.C. § 12111(3) (defining a "direct threat" as "a significant risk to the
health or safety of others that cannot be eliminated by reasonable accommodation").
143. See Stephen F. Befort, Pre-Employment Screening and Investigation:
Navigating Between a Rock and a Hard Place, 14 HOFSTRA LAB. L.J. 365, 389 (1997)
(citing Recommendations for Prevention of HIV Transmission in Health-Care Settings,
36 MORBIDITY & MORTALITY WKLY. REP., at 15S-17S) (noting the CDC's
recommendations that "health care workers who perform exposure prone procedures
voluntarily monitor their own HIV status and refrain from performing those procedures if
they become HIV infected").
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minority of states have promulgated statutes that restrict HIV
testing.44 Most of these states prohibit employers from performing
HIV tests or requiring the employee to disclose the results of tests
taken privately. 1
45
When genetic testing is compared to HIV testing, it is clear that a
genetic disorder (or hyper-susceptibility) should also be considered a
disability under the ADA. Like HIV, most genetic disorders do not
affect job performance. The only effect, if it ever manifests, will be in
the future. Furthermore, an HIV blood test has a much higher
accuracy rate than most genetic tests. 146 Like many tests for genetic
disorders, no test can predict when an individual will contract AIDS or
the individual's capability to continue a productive existence after
contracting AIDS. Unlike most genetic diseases, however, AIDS is
contagious. 4  Therefore, HIV is potentially more dangerous in the
workplace than most genetic diseases. 48 If an infectious disease such
as HIV is regulated, so should genetic testing, which poses no
contagious risk.
149
IV. GENETIC DISCRIMINATION AS A FORM OF RACIAL
DISCRIMINATION UNDER TITLE VII
At first glance, racial or ethnic discrimination based on genetic
testing seems far-fetched. After all, what could be more color-blind
than a test that identifies anomalies at the cellular level of human
biology? The lessons of history, however, teach us differently. From
the eugenics projects of the early 1900s,"5° to the discrimination that
144. See ME. REV. STAT. ANN. tit. 5, § 19204-B (West Supp. 1998) (providing that
employers may not request prospective employees to submit to HIV tests); VT. STAT.
ANN. tit. 3, § 961 (1995) (stating that employers may not discriminate against future or
current employees on the basis of HIV tests); WIs. STAT. ANN. § 103.15 (1997)
(prohibiting employers from requiring HIV tests prior to employment or discriminating
against employees because of the HIV test).
145. See ME. REv. STAT. ANN. tit. 5, § 19204-B; VT. STAT. ANN. tit. 3, § 961; Wis.
STAT. ANN. § 103.15.
146. See Joseph W. Moch & William Thompson, Suing for Misdiagnosis and
Improper Treatment of HIV, MICH. L. WKLY, Summer 1992, at 6A (stating that the ELISA
and Western Blot HIV tests are very accurate).
147. Although AIDS cannot be spread casually, it is considered an infectious disease.
148. Since there are few professions where employees are in contact with blood and
other bodily fluids on a daily basis, it is arguable that fear of contagion is not legitimate
at all because of the difficulty in spreading HIV and AIDS through casual contact.
149. The only exception is the potential danger to an individual's offspring if
conceived after the individual has contracted HIV. The danger of HIV to an unborn fetus
is outside the scope of this article.
150. See supra notes 54-63 (examining the turn of the century movement towards
418 [Vol. 30
Genetic Discrimination
arose out of the sickle cell anemia scare, 5 ' racial and ethnic
discrimination has arisen in the most unlikely places.
Advances in genetic mapping may have a disproportionate effect on
minority groups.'52 Because genetic information is complex and easily
misunderstood, it may be manipulated to legitimize existing racial and
ethnic stereotypes.'53 Some authors suggest that the potential for
manipulation may result in the creation of a biological underclass
composed mostly of minority groups.'54 For example, Patricia King
posits that when a disease occurs more frequently among a particular
minority group, two negative consequences can arise. First, members
of the minority group without the trait may be stigmatized and
discriminated against solely because they are part of a group associated
with the trait.'55 Second, a disease associated with a minority group is
less likely to be highly prioritized in the search for a treatment or
cure. 5 6 Protection, however, against this discrimination may exist
under Title VII of the Civil Rights Act of 1964 ("Title VII")'57 if
genetic testing causes discrimination that has a disparate impact on a
particular minority group.
A. Title VII
Title VII prevents discrimination in employment based upon race,
religion, nationality, color, and sex.15 Claims are brought under Title
VII through one of two theories: (1) disparate treatment theory or (2)
disparate impact theory.
classifying workers, criminals, and prospective spouses according to gene type).
151. See supra notes 64-72 and accompanying text (discussing the historic
discrimination in the United States against individuals who were carriers of the sickle
cell anemia trait).
152. See King, supra note 61, at 99-102 (reasoning that lessons from the past
suggest that current and future gene mapping efforts could potentially have a negative
impact on minority groups).
153. See id. (citing D. NELKIN & L. TANCREDI, DANGEROUS DIAGNOSTICS: THE SOCIAL
POWER OF BIOLOGICAL INFORMATION (1989)).
154. See id.
1 55. See id. King uses the potent image of the existing discrimination against gay
men who are not infected with HIV but are discriminated against because they are part of
a group that is associated with HIV and the AIDS virus. See id. at 100.
156. See id. at 100 (stating "because of [the disease's] higher frequency among the
members of an identifiable minority group, the disease might be given lower priority in
terms of research for treatment or cure").
157. 42 U.S.C. §§ 2000e (1994).
158. 42 U.S.C. §2000e-2(a)(1) (providing "[iut shall be an unlawful employment
practice for an employer to fail or refuse to hire . . . any individual . . . because of such
individual's race, color, religion, sex, or national origin").
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1. Disparate Treatment Theory
Disparate treatment discrimination is the most identifiable type of
discrimination under Title VII. "The employer simply treats some
people less favorably than others because of their race, color, religion,
sex, or national origin."' 59 The most important element in disparate
treatment discrimination is that the employer must have intended to
discriminate against the individual because of a particular trait. 6°
Although many genetic traits are linked to racial and ethnic
groups,16' a genetic marker is a facially neutral criterion. An employer
that refuses to hire all individuals who possess a specific genetic
marker is not per se discriminating against members of a single race
because many genetic diseases cross racial lines. 6 Therefore, under
the disparate treatment test, a genetic discrimination claim would likely
fail. 163  Failure is probable because it is difficult to prove an
159. Teamsters v. United States, 431 U.S. 324, 335 n.15 (1977). The Court held
that when a company engages in a pattern or practice of discrimination against
minorities in its hiring practices, it will be held in violation of Title VII of the Civil
Rights Act. See id. at 335-36.
160. In some situations a discriminatory motive may be inferred solely from the fact
of different treatment. For example, in Wroblewski v. Lexington Gardens, Inc., 448
A.2d 801 (Conn. Sup. Ct. 1982), a medical questionnaire that inquired into the
urogenital health of women, but not men, was found to violate the state discrimination
laws. Similarly, the United States Supreme Court in City of Los Angeles v. Manhart,
435 U.S. 702 (1978), held that an employer could not require women to contribute more
to their pension plans than men based on the longer life expectancy of women as a
class.
161. For example, sickle cell anemia has been linked to African Americans. See
Gostin, supra note 5, at Ill (stating that the "potential for invidious discrimination" is
increased because certain genetic diseases are intimately associated with particular racial
or ethnic groups). Bloom's Syndrome, Gaucher's disease, and Tay Sachs have been
linked to Ashkenazi Jews. See id. at 111 n.10. Familial Mediterranean fever has been
linked to Armenians. See id. at Ill n.11. Cystic fibrosis is more prevalent in
Caucasians. See Brokaw, supra note 47, at 324 n.33 (listing examples of certain genetic
traits which can be linked to specific maladies and are "concentrated among identifiable
ethnic groups"). Thalassemia has been linked to Greeks, Italians and Africans. See id.
Wilson's disease and BRCA1 (a gene linked with breast cancer) are associated with
Eastern European Jews. See Rothenberg, supra note 47, at 98-99 (discussing the link
between a genetic mutation, breast cancer and the Jewish community).
162. For example, Thalassemia affects Greeks, Italians, and Africans. See Brokaw,
supra note 47, at 324 n.33. Glucuse-6-phosphate dehydrogenase deficiency affects
Africans, Mediterranean Jews, Greeks and Filipinos. See id. (demonstrating that some
genetic ailments affect people of different races and ethnicities).
163. There would likely be a different result if the employer were to target only
members of a certain race or sex and perform the tests on members of those groups. For
example, in Norman-Bloodsaw v. Lawrence Berkeley Lab., 135 F.3d 1260, 1265-66
(9th Cir. 1998), where the employer is alleged to have tested only African Americans for
sickle cell anemia and women for pregnancy, a claim for disparate treatment under Title
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employer's intent to discriminate. Thus, any claim based on genetic
testing would have to be brought using the disparate impact theory.
2. Disparate Impact Theory
In Griggs v. Duke Power Co., 64 the Supreme Court held that Title
VII applies not only to direct discrimination, 65 but to practices that
appear neutral on their face and result in discrimination along racial
lines. The Court stated that "good intent or absence of discriminatory
intent does not redeem employment procedures or testing mechanisms
that operate as 'built-in headwinds' for minority groups and are
unrelated to measuring job capability."'' 66
To establish a disparate impact claim, an individual must prove that
the genetic screening had a discriminatory effect on groups protected
by Title VII.167 The burden then shifts to the employer to prove that
the screening is "job-related" or a "business necessity.' 68 If the
employer meets this burden, the individual can only prevail if he or she
can demonstrate that there is a less restrictive alternative to genetic
screening. 161
The prima facie case for disparate impact discrimination based on
genetic testing would be relatively easy for a job applicant to satisfy.
The plaintiff need only establish that he or-she was a member of a
minority group and was denied a job because of the results of a genetic
test that tested for a condition more prevalent in that minority group.
VII may exist. See supra note 13 (discussing the only case regarding an employer's use
of genetic testing).
164. Griggs v. Duke Power Co., 401 U.S. 424 (1971). The court found that the
practice of screening employment applicants using a specific IQ test, and requiring
applicants to have earned a high school diploma violated Title VII. See id. at 432-36.
The court reasoned that the criteria operated to disqualify African American applicants at
a substantially higher rate than white applicants and were unrelated to measuring job
capability. See id.
165. Such as when an employer refuses to hire anyone of a certain race.
166. Griggs, 401 U.S. at 432.
167. See Brokaw, supra note 47, at 332 (citing Griggs, 401 U.S. at 432, which
described the requirements for a disparate impact claim). For example, an individual
must be able to show that sickle cell anemia affects African Americans
disproportionately before he can claim racial discrimination based on the employer
conducting pre-employment testing for the trait.
168. See Griggs, 401 U.S. at 432; see also 42 U.S.C. §2000e-2(k)(1)(A) (1990)
(providing that an individual establishes a disparate impact claim where "a complaining
party demonstrates that a respondent uses a particular employment practice that causes a
disparate impact" and "the respondent fails to demonstrate that the challenged practice is
job related for the position in question and consistent with business necessity").
169. See Griggs, 401 U.S. at 432.
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3. Business Necessity and Job-Relatedness
Once the individual is able to establish a prima facie case, the burden
shifts to the employer who may try to establish that the criteria was
"job-related" or a "business necessity." While some courts have used
these terms interchangeably, 70 others have attempted to draw a
distinction between them.'7 ' "Business necessity" denotes an
employment practice whose purpose is to determine whether an
applicant is capable of performing the necessary job functions. 7 2
"Job-relatedness" has a narrower scope and concerns only whether the
employee selection criteria are reasonably related to the demands of the
job. 7 3  A determination of whether the employer satisfied either
standard depends on "a consideration of the nature of the business
involved, the business practice at issue, and the degree of
discriminatory impact."' 74 The court will then balance the "business
necessity" against the impact of the discriminatory treatment to
determine whether the genetic testing can continue.
Commentators suggest several reasons employers why may want to
use genetic testing, however, these reasons are insufficient to establish
a business necessity. For example, genetic testing may be used in an
attempt to reduce the costs of absenteeism, decreased productivity, and
increased training costs associated with training new employees who
replace sick employees.' Employers may determine the most costly
ailments and then screen for those diseases to limit the future costs of
employee illness. 7 6 Employers who cannot afford or do not want to
170. See id. at 431 (making no differentiation between the terms job-related or
business necessity). The Court stated: "[tihe touchstone [for determining whether a
practice has a discriminatory effect] is business necessity. If an employment practice
which operates to exclude Negroes cannot be shown to be related to job performance, the
practice is prohibited." Id.
17 1. See, e.g., ROTHSTEIN, supra note 69, at 134-35 (describing business necessity
as "whether there exists an overriding legitimate business purpose such that the practice
is necessary to the safe and efficient operation of business," and job-relatedness as a
comparison of legitimate "job requirements with the employer's method for assessing
fitness").
172. See id. at 134 (explaining "[t]he standards used for determining the merits of the
business necessity and job-relatedness defenses are similar").
173. See id. at 134-35 (citing Albemarle Paper" Co. v. Moody, 422 U.S. 405, 432
(1975), which stated that the employer's methods must be predictive of or significantly
correlated with important elements of the job).
174. Id. at 134.
175. See Deyerle, supra note 31, at 558 (reasoning that there may be a potential cost
savings for employers who are able to identify employees susceptible to illness).
176, See Gin, supra note 3, at 1411 (suggesting employers and insurance companies
may use genetic screening to "identify individuals who might impose 'unnecessary'
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incur the expense of extra safety measures in the workplace, may see
genetic screening as a way to prevent employment-related illnesses and
encourage worker health and safety. 177 Other commentators suggest
that genetic screening can be used to alert susceptible workers to
dangers that exist in the workplace in light of their genetic make-up. 
78
Employers may argue that this allows them to position workers in the
jobs most suited to both their talents and their susceptibilities. 7 9
The "business necessity" prong does not justify genetic testing
because the tests determine the potential of future illness, not the
existence of a present condition. Many courts have held that the
avoidance of future liability is insufficient to establish a business
necessity. 8 ° One court held that avoiding expense alone, without a
showing of a significant threat to the business, is insufficient to
overcome a Title VII discrimination claim. 8' Thus, an employer
would probably not be able to pass the business-necessity test when
using a genetic screening device that has a disparate impact on minority
applicants. Generally, present genetic tests only predict possibilities of
disease or disorders. This futuristic and unspecified threat is
insufficient to rise to the level of "business necessity."
4. Less Restrictive Means-The Plaintiff's Last Resort
Even if the employer proved a sufficient "business necessity" for
genetic testing, the plaintiff could still render the "necessity" moot by
costs in the form of high medical expenses").
177. See Deyerle, supra note 31, at 558 (stating that employers advocate such
screening to allow employees to be placed in a position for which they are best suited).
178. See Lori B. Andrews & Ami S. Jaeger, Confidentiality of Genetic Information in
the Workplace, 17 AM. J.L. & MED. 75, 76 (1991) (stating that a one-time genetic
screening could determine whether an employee could safely work in a particular job).
179. For example, when Du Pont began testing employees for benzene susceptibility
the company did not fire susceptible workers. Instead, the company moved them to
more appropriate positions. See Brokaw, supra note 47, at 323. An employer using
genetic screening to place workers in different jobs would still have to face Title VIIs
hurdles if, as a result of the testing, minorities were consistently being placed in less
desirable positions.
180. See Los Angeles Dep't of Water & Power v. Manhart, 435 U.S. 702, 716-17
(1978) (finding that future liability is insufficient to establish a business necessity);
Wright v. Olin Corp., 697 F.2d 1172, 1190 n.26 (4th Cir. 1982) (stating that future
liability alone will not create a business necessity); Myers v. Gilman Paper Corp., 544
F.2d 837, 849 (5th Cir. 1977) (suggesting that financial necessity may be considered a
business necessity only if it speaks to present financial concerns, not future ones).
181. See Chrapliwy v. Uniroyal, Inc., 458 F. Supp. 252, 259-72 (N.D. Ind. 1977)
(finding that an employer may be forced to incur large expenses in order to comply with
Title VII).
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showing less restrictive means that satisfy the same "business
necessity." If the employer sought to improve safety, this safety
should apply to all employees, rather than eliminating hyper-
susceptible workers.'82 In addition, if the workplace poses a specific
hazard to an employee, that employee should make the informed
decision whether to incur or avoid the risk.1 83
The high correlation between many genetic disorders and race or
ethnicity, prohibits screening applicants for many diseases without
violating Title VII.184 For example, tests for sickle cell anemia would
by their very nature discriminate against African Americans, a fact
recognized by many states when they prohibited employment-related
testing for the disease.185 Further, in most situations the employer
would not be able to point to a sufficient "business necessity" to justify
the testing. Even if the employer were able to establish a business
necessity, it is likely that a less-restrictive and less-invasive means
would meet that same requirement. The existence of these less-
restrictive and less-invasive means renders the discriminatory genetic
test improper. The employer may, however, be able to point to other
federal legislation such as the Occupational Safety and Health Act to
attempt to establish the necessity of conducting genetic tests.
182. See infra Part V (discussing the imposition of a general duty on employers to
provide a hazard-free work environment pursuant to certain regulations promulgated
under OSHA).
183. See International Union v. Johnson Controls, Inc., 499 U.S. 187, 211 (1991)
(finding that an employer did not have a right to exclude a woman who was of child-
bearing age from a work environment where lead was present because the "choice [was]
hers to make").
184. Some courts have sided with the employee when dealing with regulations that
have a disparate impact on minority groups. For example, in EEOC v. Trailways, Inc.,
530 F. Supp. 54 (D. Colo. 1981), the court struck down a regulation requiring bus drivers
to be clean shaven. The regulation was struck because it had a discriminatory impact on
African Americans who demonstrated a higher incidence of a skin disorder that made
shaving painful. See id. at 59. But see Woods v. Safeway Stores, 420 F. Supp. 35 (E.D.
Va. 1976) (upholding the dismissal of African American employees who grew beards as a
result of a skin condition where customers found bearded workers in a grocery store
distasteful). Similarly, most of the employers who pioneered sickle cell testing soon
stopped, and some states have now prohibited the testing because of its disparate impact
on African Americans.
185. See generally FLA. STAT. ANN. § 448.076 (West 1997) (prohibiting sickle cell
trait screening as a condition of employment); LA. REV. STAT. ANN. § 23:352 (West
1998) (prohibiting employment discrimination on the basis of sickle cell trait).
1999] Genetic Discrimination 425
V. THE OCCUPATIONAL SAFETY AND HEALTH ACT: No SAFE
HARBOR FOR EMPLOYERS THAT USE GENETIC TESTING
The Occupational Safety and Health Act ("OSHA") was passed in
1970. By enacting OSHA, Congress intended "to assure so far as
possible every working man and woman in the Nation safe and
healthful working conditions and to preserve our human resources."'
' 86
OSHA imposes two duties on employers. First, employers have a
general duty to provide places of employment "free from recognized
hazards that are causing or are likely to cause death or serious physical
harm." '87 Recognized hazards are those known to the employer or
recognized as a hazard by the industry.'88 To establish a recognized
hazard a plaintiff must show that the employer had actual or
constructive knowledge of the hazard, or that the employer's standards
were below the general industry standards.'89 Second, each employer
must comply with safety regulations promulgated under OSHA. 9°
A. An Employer's General Duty
Under OSHA, an employer is not required to provide a perfectly
safe working environment.' The employer is only required to
eliminate significant risks of hazard as much as possible. 192 The
general duty to provide a safe workplace arguably requires employers
186. 29 U.S.C. § 651 (1994).
187. Id. § 654(a)(1).
188. See Jack F. Williams, A Regulatory Model for Genetic Testing in Employment,
40 OKLA. L. REv. 181, 190-91 (1987) (noting that a recognized hazard may be shown
through actual or constructive knowledge on the employer's part or by reference to an
industry practice. However, the fact that an industry has not previously addressed a
certain hazard does not "foreclose a court's inquiry").
189. See Magma Copper Co. v. Marshall, 608 F.2d 373, 375-76 (9th Cir. 1979)
(stating that an employer's actual knowledge of a hazard is sufficient proof that the
hazard was recognized).
190. See Williams, supra note 188, at 190 n.61 (discussing the Secretary of Labor's
authority to set standards requiring "conditions, or the adoption or use of one or more
practices, means, methods, operations, or processes, reasonably necessary or
appropriate to provide safe or healthful employment and places of employment").
191. See Judith Richter, Taking the Worker as You Find Him, 8 MD. J. CONTEMP.
LEGAL ISSUES 189, 212-13 (1997); see also Industrial Union Dep't v. American
Petroleum Inst., 448 U.S. 607, 615 (1980) (holding that the Secretary's standard for
Benzene was too low and not "reasonably necessary or appropriate to provide safe and
healthful employment").
192. See Ellen R. Peirce, The Regulation of Genetic Testing in the Workplace-A
Legislative Proposal, 46 OHIO ST. L.J. 771, 814 (1985) (discussing employers'
concerns with genetic testing in the workplace in connection with an employer's
common law duty to test and OSHA compliance).
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to genetically test employees and applicants for hyper-susceptibility to
known toxins. Specifically, if an employer knows, or should know,
that a certain toxin can be excessively dangerous to hyper-susceptible
individuals, then the employer places these individuals at increased
risk by hiring and exposing them to a hazardous work environment.
This argument is unpersuasive for several reasons.
B. Safety Regulations Under OSHA
OSHA empowers the Secretary of Labor to create standards that
require medical testing of employees exposed to certain toxins in the
workplace.1 93 The Secretary of Labor, however, is not required to
draft regulations to eliminate all toxins in the workplace, or even to
eliminate any toxin in its entirety.'94 Rather, regulations must be
technologically and economically feasible. 95 Further, they should
focus on the workplace, and not the individual workers. 196 Therefore,
any safety standard designed to protect the hyper-susceptible worker
would probably be successfully challenged as either unreasonable or
infeasible. 197 Yet, the Secretary of Labor is allowed to "prescribe the
type and frequency of medical examinations... which shall be made
available, by the employer or at his cost . . . in order to most
effectively determine whether the health of such employees is
adversely affected by such exposure."' 98
193. See 29 U.S.C. § 651(b)(3) (1994) (authorizing "the Secretary of Labor to set
mandatory occupational safety and health standards applicable to businesses affecting
interstate commerce").
194. See Industrial Union Dep't, 448 U.S. at 614.
195. While OSHA does not give a specific definition of what it means to be
economically or technologically feasible, courts have interpreted the requirement to
mean that an employer may have to expend significant amounts of money before
successfully claiming that a standard is economically infeasible. For example, courts
have held that a standard will not be considered economically infeasible merely because
the cost is high. See Asarco, Inc. v. OSHA, 746 F.2d 483, 501 (9th Cir. 1984); United
Steelworkers of Am. v. Marshall, 647 F.2d 1189, 1307 (D.C. Cir. 1980) (finding that
high cost alone did not make a standard economically infeasible). The cost must be
weighed against the expected benefit in determining whether the standard is appropriate.
See United Parcel Serv. v. OSHA, 570 F.2d 806, 812 (8th Cir. 1978) (holding that the
UPS need not require its employees to wear steel-toed shoes where the cost outweighed
the potential safety benefit).
196. See 29 U.S.C. § 651(b)(1) (stating the first purpose of the act is "to reduce the
number of occupational safety and health hazards at ... places of employment").
197. See Peirce, supra note 191, at 814 (stating that the standard "might be
challenged as not reasonably necessary or appropriate to provide safe and healthful
employment or because it is technologically or economically infeasible").
198. 29 U.S.C. § 655(b)(7).
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Currently, OSHA's medical surveillance regulations require pre-
employment or pre-placement examinations. Following the
examination, the treating physician must give the employer a statement
that the employee is suitable for the desired position. Additionally, the
employee is periodically tested during the term of employment.
99
These tests range in level of invasiveness from a simple physical
examination to blood and urine analysis.2 °° Currently, none of these
regulations require disclosure of uncovered genetic information.
Theoretically, however, under the auspices of the Act, the Secretary of
Labor could create a rule that requires employers to genetically test
employees and applicants for known susceptibilities to certain
toxins.20 ' The legitimacy of this rule would depend on the cost of the
test, its accuracy, and the feasibility of requiring its widespread use in
the industry.0 2 At present, it is doubtful that any genetic test would
meet these criteria because most genetic tests are currently expensive
and unreliable.2 3
199. See Mark A. Rothstein, Employee Selection Based on Susceptibility to
Occupational Illness, 81 MICH. L. REv. 1379, 1414 (1983) ("[E]mployers must conduct
preplacement examinations, the physician must furnish employers with the physician's
statement of suitability for employment in the regulated areas, the employer must
conduct periodic (usually annual) examinations.").
200. See 29 C.F.R. § 1910.1001 (1998) (requiring pulmonary function tests and
chest x-rays for exposure to asbestos); 29 C.F.R. § 1910.1017 (requiring complete
physical exam and liver studies for exposure to polyvinyl chloride); 29 C.F.R. §
1910.1025 (requiring a complete medical exam and detailed blood analysis for exposure
to lead), 29 C.F.R. § 1910.1044 (requiring examination of genitourinary tract and serum
specimen analysis by radioimmunioassay).
201. See Williams, supra note 188, at 192 (discussing genetic testing in light of
feasibility standards).
202. Courts have found that when determining whether a standard is appropriate the
cost of the measure must be balanced against the expected benefit. The benefit,
however, must be given more weight than the cost in determining whether the standard
should be passed. See RMI Co. v. Secretary of Labor, 594 F.2d 566, 572 (6th Cir. 1979)
(suggesting that cost must be balanced against benefit, but that the benefit should be
given greater weight than the cost); United Parcel Serv. v. OSHA, 570 F.2d 806, 812
(8th Cir. 1978) (ruling that foreseeable hazards must be eliminated even if costly);
American Petroleum Inst. v. OSHA, 581 F.2d 493, 502-03 (5th Cir. 1978) (requiring a
balancing test between cost and benefit of the proposed standard).
203. The expense of genetic tests outweighs their benefit since most genetic tests are
still considered inaccurate predictors of hyper-susceptibility. See Brokaw, supra note
47, at 321; Deyerle, supra note 31, at 551-52. Without an accurate measure, it is
unlikely that any genetic testing requirement would withstand a challenge.
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The broad goal of OSHA is to limit workplace toxins.2 °4 OSHA
focuses specifically on the workplace, not the individual worker.2 °5
Identifying and excluding hyper-susceptible workers from known
toxins contradicts OSHA's goal to provide safe workplaces "free from
recognized hazards that are causing or are likely to cause death or
serious physical harm. 20 6 Rather than reducing workplace toxins,
broad-scale genetic testing and exclusion of hyper-susceptible workers
would encourage employers to continue operating hazardous work
sites while at the same time creating a class of unemployable workers.
The better approach, and the one supported by OSHA's general
goals,2 7 is to reduce or eliminate workplace toxins and implement
safety procedures that would give all workers, hyper-susceptible or
not, a safer work environment.2 8
OSHA would not prohibit genetic testing in the workplace, but it
does not permit the actual use of information gained from the tests.
The goal of OSHA is to improve the workplace, not exclude certain
workers from certain jobs. Therefore, OSHA does require testing of
employees where workplace includes known toxins. Given an
accurate and fairly inexpensive test, OSHA could possibly require
employers to conduct certain genetic tests on employees in the future.
With current genetic technology, however, this requirement is unlikely
because any genetic test would probably fail the economically and
technologically feasible test that is applied to OSHA standards. In
addition, it is doubtful that an employee could use the general duty
204. See 29 U.S.C. § 651(b) (1994) (stating that the act's goal is to "provide safe
and healthful working conditions").
205. See Peirce, supra note 192, at 817-18 (claiming that genetic testing does not
create a safe working environment); Richter, supra note 191, at 217 (explaining that
under OSHA, genetic testing is not a general duty of employers).
206. 29 U.S.C. § 654(a)(1).
207. OSHA's general duty clause provides that every employer "shall furnish to each
of his employees employment and a place of employment which are free from recognized
hazards that are causing or are likely to cause death or serious physical harm to his
employees." 29 U.S.C. § 654(a)(i).
208. Genetic testing should not be permitted under OSHA because it should be up to
the hyper-susceptible worker to determine whether he or she is willing to risk exposure
to toxins at levels that are relatively safe for the "normal" person. See International
Union v. Johnson Controls, Inc., 499 U.S. 187, 220 (1991) (invalidating a regulation
which prevented fertile women from working in conditions with high lead levels and
reasoning that women have the right to decide where to work). Further, past OSHA
administrators have given public statements disapproving of genetic testing of
employees under OSHA. See Peirce, supra note 192, at 818 (claiming that genetic
testing does not fit into the general duty clause) (citing Bingham, Letter to the Editor,
N.Y. TIMES, Mar. 22, 1980, at A20).
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clause to justify conducting genetic testing because the testing would
only accomplish restricting access to jobs, not increasing the overall
safety of the workplace.
Another area of protection against genetic testing may come from
constitutionally protected privacy rights. These protections will be
especially strong for public employees who are protected by the Fourth
Amendment against unlawful searches and seizures.
VI. THE RIGHT TO PRIVACY AND GENETIC INFORMATION
Although not specifically enumerated in the Constitution, the
Supreme Court recognized a right to privacy in Griswold v.
Connecticut2°9 through a combination of the First, Third, Fourth and
Fifth Amendments to the United States Constitution.210 To fall within
this zone of privacy, a right must be either "implicit in the concept of
ordered liberty,"'' or "deeply rooted in this Nation's history and
tradition."2"2 To date, however, no recognized constitutional right to
privacy would prohibit employment testing.213
A. Right to Privacy in Medical Information
In Whalen v. Roe,2 14 the Supreme Court recognized a right to
privacy in medical information. 2 5 The Court considered a New York
statute that required the state to record prescription drug user names
and addresses.21 6  The Court held that the zone of privacy
encompassed an individual's interest against disclosure of personal
209. Griswold v. Connecticut, 381 U.S. 479 (1965) (establishing a married couple's
right to privacy within their own bedroom).
210. See U.S. CONST. amends. I, III, IV, V. Plaintiffs in California may be provided
an extra level of protection because the California Constitution includes within it a right
to privacy. See CAL. CONST. art. I, § 1.
211. Bowers v. Hardwick, 478 U.S. 186, 191-92 (1986) (upholding a criminal
sodomy law and declining to find a Constitutional right to engage in homosexual
relations).
212. Id. (quoting Moore v. East Cleveland, 431 U.S. 494, 503 (1977)).
213. See Deyerle, supra note 31, at 563, (discussing the treatment of Griswold v.
Connecticut by lower courts in the context of genetic testing); Peirce, supra note 192, at
801 (finding no Supreme Court decision concerning an employee's right to privacy in
the workplace).
214. Whalen v. Roe, 429 U.S. 589 (1977).
215. See id. at 598-600 (upholding a New York patient identification statute where
the statute did not substantially invade an individual's right to privacy in medical
information).
216. See id. at 591.
1999] 429
430 Loyola University Chicago Law Journal [Vol. 30
information such as prescription drug use. 217 The Court, however,
found the statute was constitutional because the interest of the state in
collecting the information outweighed the individual's interest in
keeping it private.1 8
Arguably, because genetic information is uniquely personal, it
deserves more protection than other forms of medical information.219
The information available through our genes, including the potential to
unlock secrets unknown even to the individual, highlights the unique
nature of genetic information.220 In addition, genetic information
carries implications not only for the individual but also for his or her
family.22' History, therefore, should be a guide to determine the scope
of privacy applicable to genetic information.222 Specifically, the
release of genetic information conjures up the specters of social
stigma, employment and insurance discrimination, and ultimately
creates a genetic underclass.223
217. See id. at 598-600.
218. See id. at 600.
219. But see Thomas H. Murray, Genetic Exceptionalism and "Future Diaries": Is
Genetic Information Different from Other Medical Information?, in GENETIC SECRETS
PROTECTING PRIVACY AND CONFIDENTIALITY IN THE GENETIC ERA 60, 62 (Mark A. Rothstein
ed., 1997). Murray argues that "genetic information is neither unique nor distinctive" in
offering a view of an individual's future health. Id. at 64. He further suggests that
genetic information and risk factors are no different than other medical information and
risk factors. See id. at 69. Murray analogizes an individual's genetic make-up to a diary,
stating:
Our genes might be regarded metaphorically as the physical, but blank,
volume in which we will create our diary. Some volumes have fewer pages in
which to write, some more. Certain pages, often toward the back of the
volume, may be more difficult to write on. And some leaves may require great
skill and effort to open at all. But the physical volume is not the content of
the diary. The content we must write ourselves.
Id. at 72.
220. See Lawrence 0. Gostin, Genetic Privacy, 23 J.L. MED. & ETHICS 320, 324-26
(1995) (discussing the need for genetic privacy statutes, particularly in a health system
with computerized medical records).
221. See id. at 324. This argument can be carried further to suggest that an
individual's genetic information may have far-reaching implications for those in the
same racial or ethnic group. See supra Parts II, IV (providing a further discussion of
racial and ethnic implications for genetic testing).
222. See supra Part II (discussing past misuses of genetic information). Toward this
end, many proposals for genetic privacy acts have been made, including a proposed
"Genetic Privacy Act" and Congressional "genetic privacy" bills. See Anita L. Allen,
Genetic Privacy: Emerging Concepts and Values, in GENETIC SECRETS-PROTECTING
PRIVACY AND CONFIDENTIALITY IN THE GENETIC ERA 31 (Mark A. Rothstein ed., 1997)
(defining and discussing the regulation of genetic privacy); see also Gurd, supra note
104, at 118 (discussing the relationship between genetic discrimination and the ADA).
223. See Allen, supra note 222, at 32 (warning against sacrificing privacy for
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B. Fourth Amendment Protections
Public employees gain another layer of protection against genetic
testing through the Fourth Amendment of the United States
Constitution. The Fourth Amendment provides protection against
unreasonable searches and seizures. 4 The Supreme Court has stated
that "the overriding function of the Fourth Amendment is to protect
personal privacy and dignity against unwarranted intrusion by the
State." '225 Generally, the Fourth Amendment speaks to criminal
searches. In certain situations, however, the Fourth Amendment
protections have been applied to noncriminal searches as well.
1. Genetic Tests as Unlawful Searches
In O'Connor v. Ortega,226 the Supreme Court applied the Fourth
Amendment to analyze the invasion of a government employee's
privacy. 227  The Court found that a government employee had an
expectation of privacy within his locked desk and office filing
cabinet. 228 Two years later, the Supreme Court found that a drug test
was a search within the meaning of the Fourth Amendment. 9 In so
doing, the Court set up a balancing test for employee drug testing.
Under this test, the government's interest is balanced against the
employee's privacy interest.
230
Where a government employer requires applicants or employees to
submit to a genetic test, the government undertakes a search within the
meaning of the Fourth Amendment.231  Although a specific case has
science); King, supra note 61, at 100 (discussing the correlation between current genetic
testing and past racial stereotypes).
224. See U.S. CONST. amend. IV. The amendment provides, in pertinent part, "[t]he
right of the people to be secure in their persons, papers, and effects, against
unreasonable searches and seizures, shall not be violated." Id.
225. Schmerber v. California, 384 U.S. 757, 767 (1966) (holding that withdrawal of
blood to conduct a blood-alcohol test does not violate the Fourth Amendment).
226. O'Connor v. Ortega, 480 U.S. 709 (1987).
227. See id. at 714 (stating that the hospital conducted a search of one of its doctor's
offices due to suspicion about the doctor's management of a residency program).
228. See id.
229. See Skinner v. Ry. Labor Executives' Ass'n, 489 U.S. 602, 633 (1989)
(upholding random drug testing of railroad employees).
230. See id. at 619.
231. Currently, the largest government collector of genetic material is the United
States Military. Through the Department of Defense DNA Registry and Repository,
every American service member, and civilian employee located in a potential combat
zone, is compelled to provide blood and tissue samples to the government. The samples
are maintained in a large databank. Unlike other genetic material collection, however,
this information is not being used to deny employees jobs or promotions. The stated
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not addressed the Fourth Amendment's application to genetic
testing,232 it is likely that courts would borrow from drug testing
jurisprudence and balance the individual's privacy interest against the
government's interest in the test.
233
An individual's interest in maintaining the privacy of genetic
information is high due to the unique information contained within
human genes. Unlike minimally intrusive tests, such as drug or
purpose of the databank is to assist the government in identifying remains of service
members if needed during a military conflict. See generally Robert Craig Scherer, Note,
Mandatory Genetic Dogtags and the Fourth Amendment: The Need for a Post-Skinner
Test, 85 GEO. L.J. 2007 (1997) (arguing that the current non-consensual, non-criminal
testing of government employees is outmoded and should be replaced). In Mayfield v.
Dalton, the district court of Hawaii upheld the constitutionality of the Registry. See
Mayfield v. Dalton, 901 F. Supp. 300, 303-05 (D. Haw. 1995), vacated by Mayfield v.
Daulton, 109 F.3d 1423 (9th Cir. 1997). The court found that the important interest of
the government in identifying remains outweighed the individual's privacy interest. See
id. The appeal of the case, however, was summarily dismissed as moot because the
servicemen involved had since been honorably discharged from the military. See
Mayfield, 109 F.3d 1423 (9th Cir. 1997), vacating as moot 901 F. Supp. 300, 303-05.
232. The Ninth Circuit has recognized the possibility of a privacy claim based on
genetic testing in a state and federally owned laboratory. See Norman-Bloodsaw v.
Lawrence Berkeley Lab., 135 F.3d 1260, 1269 (9th Cir. 1998) (acknowledging a cause
of action based on privacy interests under both the United States Constitution and the
California Constitution, where the lab did testing for syphilis, sickle cell anemia, and
pregnancy without an individual's knowledge).
233. This same balancing test has been applied by lower courts for mandatory AIDS
testing in the workplace. In Local 1812 v. United States Department of State, the union
challenged the government's mandatory HIV testing policy. See Local 1812 v. United
States Dep't of State, 662 F. Supp. 50, 51 (D.D.C. 1987). The government argued that
service by HIV-infected individuals at many foreign posts would pose a "serious hazard"
to the infected individual because of the poor medical facilities and poor quality of other
health and sanitary conditions. See id. at 52. The court upheld the test, finding it was
minimally intrusive because blood testing for other conditions was already required. In
addition, the court found that the tests were rationally related to fitness for duty. See id.
at 54. The Fifth Circuit followed similar reasoning in upholding the discharge of a nurse
from a hospital who refused to submit the results of an HIV-test he had voluntarily taken
outside the course of his employment. See Leckelt v. Board of Comm'rs, 909 F.2d 820,
833 (5th Cir. 1990). The court applied a balancing test and determined that the
hospital's interest "in maintaining a safe workplace through infection control
outweighed the limited intrusion on any privacy interest of Leckelt in the results of his
HIV antibody test." Id. at 833.
In contrast, the Eighth Circuit struck down a health service's mandatory HIV-testing
policy. See Glover v. Eastern Neb. Community Office of Retardation, 867 F.2d 461,
464 (8th Cir. 1989). The agency argued that it was necessary to test employees for HIV
because mentally retarded individuals often scratched and bit workers. See id. at 463.
The court based its decision on the fact that there was no conclusive evidence that the
disease could be spread through casual contact. See id. The court found that "from a
medical viewpoint, this policy is not necessary to protect clients from any medical
risks." Id. at 463.
Genetic Discrimination
alcohol tests, genetic tests reveal traits beyond an individual's control.
The government's interest, however, in this genetic information about
its employees is relatively low. Generally, this information does not
reveal anything about an individual's present ability to perform job
functions safely and successfully. Rather, the information may reveal
risks to the individual, but not risks to fellow workers.2 34 Admittedly,
the government can express some interest in the protection of its
workers against unnecessary risk of disease. A paternalistic reason,
however, is not sufficient to overcome the individual's interest in
privacy."'
2. Genetic Tests as Unlawful Seizures
Government employees also have some protection against genetic
testing based on the privacy rights against illegal seizures inherent in
the Constitution. Taking an individual's blood or tissue for the
purposes of genetic testing is a type of seizure protected by the Fourth
Amendment.236 In order to make this seizure, the government would
have to establish an overwhelming need for the test. Yet, this need
may be difficult to establish. Unlike drug testing that only tests for the
existence of a limited number of substances voluntarily ingested by the
individual, genetic testing reveals the deepest secrets of an individual's
past, present, and projected future including those of his or her family.
This added level of invasiveness strengthens the individual's privacy
interest thus raising the government's burden in showing a need to
justify an intrusion. The government, therefore, would be hard-
pressed to articulate a satisfactory need.
VII. STATE LEGISLATION-AN ATTEMPT TO CLARIFY THE LAW OF
GENETIC TESTING
In response to the confusion over whether federal laws protect
against genetic discrimination, many states have stepped in and passed
their own legislation. 237 The laws range from total protection against
234. Risks to fellow workers include risks such as those inherent in drug use at
dangerous work sites or AIDS testing in a medical facility. These risks could arguably
support intrusive testing to secure the safety of co-workers. See Leckelt, 909 F.2d at
833.
235. See International Union v. Johnson Controls, Inc., 499 U.S. 187, 206 (1991)
(striking down a company's policy that disqualified fertile females from working near
lead).
236. The Fourth Amendment guarantees an individual the right to be free from
"unreasonable searches and seizures." U.S. CONST. amend IV.
237. Most of the state legislation refers only to discrimination in insurance, and not
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genetic testing to limited restrictions on the use of such tests. Unlike
the ADA, the protections in the state laws are not restricted to
employers with fifteen or more employees.
In 1981, the state of New Jersey was the first to enact legislation
addressing employment discrimination based on genetic testing. This
law prohibited "employment discrimination based on an individual's
'atypical hereditary cellular or blood trait.' ' 238 In 1996, New Jersey
revised this law to ban discrimination based,on "genetic information"
including information "that may derive from an individual or family
member.,
239
Other states in the years to follow, however, have provided the most
comprehensive protection. 4 ° Wisconsin, Iowa and New Hampshire
employment. See NEB. REV. STAT. ANN. § 689A.417 (Supp. 1997) (prohibiting health
insurers from requiring the insured or any member of his family to take a genetic test,
disclose whether he or any member of his family had previously taken a genetic test, or
determine the rates or other aspects of coverage based on whether the individual or a
family member had taken a genetic test, or any other genetic information). The
prohibition, however, is not extended to an insurer "who issues a policy of health
insurance that provides coverage for long-term care or disability income." Id.; see also
COLO. REV. STAT. ANN. § 10-3-1104.7 (West Supp. 1997) (preventing genetic testing
from being used to deny "health care insurance, group disability insurance, [and] long-
term care insurance." The statute specifically exempts life insurance and individual
disability insurance.); FLA. STAT. ANN. § 627.4301 (Supp. 1998) (preventing health
insurers from canceling, limiting or denying coverage, or establishing differentials in
premium rates, based on genetic information in the "absence of a diagnosis of a
condition related to genetic information"); 410 ILL. COMP. STAT. 513/20 (West 1997)
(providing that an insurer may not use genetic testing in connection with accident and
health insurance. The law makes an exception when the genetic testing information is
provided voluntarily by the individual and the results are favorable to that individual.);
GA. CODE ANN. 33, ch. 54-1, -3, -7 (1996) (preventing "accident and sickness insurance
companies, health maintenance organizations, managed care organizations, and other
payors from using genetic information to deny accident and sickness coverage); N.H.
REV. STAT. ANN. § 141-H:4-5 (1996) (providing that a health insurance company may
not require or request an individual or his family to undergo genetic testing or reveal
whether the individual or his family has previously taken a genetic test. An exception is
provided, however, for "life insurance, disability income insurance, [and] long-term care
insurance."). A complete discussion of the limitations on genetic discrimination in
insurance is beyond the scope of this paper.
238. Mark A. Rothstein, The Law of Medical and Genetic Privacy in the Workplace,
in GENETIC SECRETS: PROTECTING PRIVACY AND CONFIDENTIALITY IN THE GENETIC ERA 281,
291 (1997) (citing N.J. STAT. ANN. § 10:5-5(x) (West 1993), which states that "[a]
typical hereditary cellular or blood trait" means sickle cell trait, hemoglobin C trait,
thlassemia trait, Tay Sachs trait, or cystic fibrosis trait").
239. Id.
240. These states are Wisconsin, Iowa, and New Hampshire. See WIs. STAT. ANN. §
111.372 (West 1997) (Use of Genetic Testing in Employment Situations); N.H. REV.
STAT. ANN. § 141.H:3 (1996) (Use of Genetic Testing in Employment Situations); IOWA
CODE ANN. § 729.6 (West 1993) (Genetic Testing).
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provide virtually identical statutory provisions:24'
No employer, labor organization, employment agency, or
licensing agency shall directly or indirectly: (a) [s]olicit, require
or administer genetic testing relating to any individual as a
condition of employment, labor organization membership, or
licensure[;] (b) [a]ffect the terms, conditions, or privileges of
employment, labor organization membership, or licensure or
terminate the employment, labor organization membership, or
licensure of any individual based on genetic testing.242
The statute goes on to provide that "[a]ny agreement between an
employer, labor organization, employment agency, or licensing agency
and an individual offering employment, labor organization member-
ship, licensure, or any pay or benefit to that individual in return for
taking a genetic test is prohibited., 243  The statute, however, does
provide an exception that permits employee testing under limited
circumstances, but prohibits termination based on the results of these
tests.2 " In effect, this eliminates virtually all chance of discrimination
based on latent genetic defects. It is more restrictive than the ADA
medical testing provisions because it does not allow genetic testing at
any stage of the employment relationship. By allowing testing for
susceptibility to workplace toxins, while still preventing negative
employment decisions based on the results, the statute protects
workers from harmful environments and discrimination.245 It may,
however, restrict paternalistic employment decisions that seek to
transfer hyper-susceptible employees to a safer work environment. If
the employee views the transfer as an adverse employment action, the
transfer may be prevented even though the employer had good
intentions.246
241. The New Hampshire statute is cited by way of example. See N.H. REV. STAT.
ANN. § 141-H:3.
242. Id. § 141-H:3(I)(a)-(b).
243. Id. § 141-H:3(III).
244. See id. § 141-H:3 (IV)(b) (allowing consensual genetic testing to determine an
"employee's susceptibility or level of exposure to potentially toxic chemicals or
potentially toxic substances in the workplace, if the employer does not terminate the
employee, or take any other action that adversely affects any term, condition, or
privilege of the employee's employment") (emphasis added).
245. Note, however, that while the employers may test for susceptibility to
workplace toxins, there is no requirement that the employer move the employee out of
the hazardous workplace if susceptibility is found. There is also no requirement that the
test results be revealed to the employee. Thus, the law may not provide as much
protection against workplace toxins as it appears at first glance. See id. §141-H'3.
246. North Carolina provides similar protection. See N.C. GEN. STAT. § 95-28.1A
(Michie Supp. 1997). The statute, titled "Discrimination Against Persons Based on
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Given the confusion over the protections provided in federal
legislation such as the ADA, more states will likely follow suit in
enacting statutes specifically aimed at protecting workers against
genetic discrimination in the future.247
VIII. CONCLUSION
Genetic research promises a wealth of medical benefits. When
diseases can be identified and linked to genetic traits there is a promise
of treatment and cure in the future. The Human Genome Project's
goal of identifying all 100,000 human genes within the next ten years
holds the promise of healthier, longer lives. With this promise,
however, lies the specter of fear and discrimination.
Genetic testing may be applied in employment to discriminate
against "genetically inferior" workers. Employers have an interest in
healthy, productive workers who will remain with the company far
into the future. Unhealthy workers cost a company money in lost
time, insurance, and retraining to replace seriously ill workers. This
vision includes a picture of employers who screen applicants and
Genetic Testing or Genetic Information Prohibited," states that:
No person, firm, corporation, unincorporated association, State agency, unit
of local government, or any public or private entity shall deny or refuse
employment to any person or discharge any person from employment on
account of the person's having requested genetic testing or counseling
services, or on the basis of genetic information obtained concerning the
person or a member of the person's family.
Id. Theoretically, this does not prevent employers from requiring genetic testing. There
would be little purpose to the testing, however, because the employer is prevented from
acting upon anything he or she discovers. See id.
247. For example, New York law statutes include the language "genetic predis-
position or carrier status" in its existing discrimination laws. See N.Y. EXEC. LAWS §
296 (1)(a) (McKinney Supp. 1998) (Unlawful Discrimination Practices). Thus, under
New York law, genetic "predisposition or carrier status" is raised to the level of "age,
race, creed, color, national origin, sex, disability . . .[and] marital status" in terms of
protection against employment discrimination. Id. Additionally, an Oregon statute
makes it an "unlawful employment practice for an employer to seek to obtain, to obtain,
or to use genetic information ... of an employee or a prospective employee to
distinguish between or discriminate against ... an employee or prospective employee."
OR. REv. STAT. § 659.036(1) (Lexis Supp. 1996). The law, however, includes an
exception for the use of genetic information with the authorization of the employee to
determine a "bona fide occupational qualification." Id. The law does not define a "bona
fide occupational qualification," thus diminishing the strength of a law that without this
caveat, could have protected virtually all employees from genetic discrimination. Id.
Additionally, section 659.227 of the Oregon statute prohibits an employer from
subjecting an employee or prospective employee to genetic testing, again with the
exception that the genetic test be administered to determine a "bona fide occupational
qualification." Id. § 659.227(1).
Genetic Discrimination
refuse employment based on genetic markers correlated with serious
diseases. While this seems futuristic, research has shown that genetic
testing in the employment arena is a reality.248 As genetic tests get
easier, cheaper, and more accurate, their use is likely to increase if
proper guidelines are not established.
Workers currently have many protections in place against the
abusive use of genetic testing. First, the ADA provides employees
with their greatest protection. It dictates how and when medical
testing-and by extension, genetic testing-may be performed. In
addition, employees may gain added protection through Title VII when
a specific genetic disorder is correlated along racial, ethnic, or gender
lines.
OSHA may also add a layer of protection. Under OSHA, the
Secretary of Labor may promulgate regulations that require genetic
testing in certain work environments. These tests, however, would be
government regulated and only administered in limited situations.
Further, an employer cannot hide behind the dictates of OSHA's
general duty clause to justify its own implementation of genetic testing
because the clause requires employers to provide a safe environment
for all employees, not just the genetically susceptible ones.
Finally, government employees gain an added layer of protection
from privacy rights inherent in the Constitution. Like drug testing,
genetic testing is a type of seizure protected by the Fourth Amendment.
In order to use a genetic test, the government would have to establish
an overwhelming need for the test. Unlike drug testing, which only
tests for the existence of a few limited substances taken voluntarily by
the individual, genetic testing reveals the deepest secrets of an
individual. This invasiveness strengthens the individual's privacy
interest and heightens the government's burden to establish "need" in
order to overcome it.
Yet, despite all these protections, it remains unclear whether any of
these laws actually apply to genetic discrimination. Many
commentators suggest that these laws are insufficient to protect
workers from unjustified genetic discrimination. Toward this end,
many states have passed their own laws protecting individuals within
their borders from genetic discrimination in employment. A simple
statement from Congress including latent genetic disorders as a
248. See GENETIC MONITORING SURVEY, supra note 2 (discussing the feasibility of
genetic tests currently utilized in the employment setting); see also notes 4-9 and
accompanying text (stating that at least 20 Fortune 500 companies have admitted to
using genetic testing at one time or another).
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disability under the ADA would resolve this issue and guarantee that
employees are protected from genetic discrimination in the future.
